JP2020125291A - Antiperspirant composition for scalp - Google Patents
Antiperspirant composition for scalp Download PDFInfo
- Publication number
- JP2020125291A JP2020125291A JP2020013996A JP2020013996A JP2020125291A JP 2020125291 A JP2020125291 A JP 2020125291A JP 2020013996 A JP2020013996 A JP 2020013996A JP 2020013996 A JP2020013996 A JP 2020013996A JP 2020125291 A JP2020125291 A JP 2020125291A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- scalp
- component
- antiperspirant
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 154
- 239000000203 mixture Substances 0.000 title claims abstract description 105
- 230000001166 anti-perspirative effect Effects 0.000 title claims abstract description 85
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 85
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 84
- 241000894006 Bacteria Species 0.000 claims abstract description 62
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims abstract description 47
- 229960003720 enoxolone Drugs 0.000 claims abstract description 24
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims abstract description 23
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940081510 piroctone olamine Drugs 0.000 claims abstract description 15
- 229940043810 zinc pyrithione Drugs 0.000 claims abstract description 15
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 14
- -1 chlorohydroxyaluminum Chemical compound 0.000 claims description 138
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 42
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 42
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 claims description 37
- 239000000843 powder Substances 0.000 claims description 36
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 34
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 15
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 10
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 10
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 7
- 229960000458 allantoin Drugs 0.000 claims description 7
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 7
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 5
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960001950 benzethonium chloride Drugs 0.000 claims description 5
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 5
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 claims description 5
- 229960003500 triclosan Drugs 0.000 claims description 5
- 229960001325 triclocarban Drugs 0.000 claims description 4
- 210000004243 sweat Anatomy 0.000 abstract description 17
- 239000000284 extract Substances 0.000 description 49
- 238000012360 testing method Methods 0.000 description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
- 229920001296 polysiloxane Polymers 0.000 description 43
- 239000003795 chemical substances by application Substances 0.000 description 41
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 35
- 230000000694 effects Effects 0.000 description 33
- 235000019645 odor Nutrition 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 28
- 235000002639 sodium chloride Nutrition 0.000 description 26
- 235000014113 dietary fatty acids Nutrition 0.000 description 25
- 229930195729 fatty acid Natural products 0.000 description 25
- 239000000194 fatty acid Substances 0.000 description 25
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 24
- 238000009472 formulation Methods 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 230000002708 enhancing effect Effects 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 239000000654 additive Substances 0.000 description 19
- 230000000996 additive effect Effects 0.000 description 19
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 18
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 17
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 17
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 17
- 239000005642 Oleic acid Substances 0.000 description 17
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 17
- 238000011156 evaluation Methods 0.000 description 17
- 230000005764 inhibitory process Effects 0.000 description 17
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 17
- 235000021313 oleic acid Nutrition 0.000 description 17
- 239000000454 talc Substances 0.000 description 17
- 229910052623 talc Inorganic materials 0.000 description 17
- 239000000443 aerosol Substances 0.000 description 16
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 15
- 210000003128 head Anatomy 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 239000000377 silicon dioxide Substances 0.000 description 15
- 241000191940 Staphylococcus Species 0.000 description 14
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 14
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 14
- 229940117972 triolein Drugs 0.000 description 14
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 13
- 239000003380 propellant Substances 0.000 description 13
- 229940088594 vitamin Drugs 0.000 description 13
- 229930003231 vitamin Natural products 0.000 description 13
- 235000013343 vitamin Nutrition 0.000 description 13
- 239000011782 vitamin Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 12
- 229910052782 aluminium Inorganic materials 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 229930007845 β-thujaplicin Natural products 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 11
- 229920006037 cross link polymer Polymers 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 230000037358 bacterial metabolism Effects 0.000 description 10
- 239000003595 mist Substances 0.000 description 10
- 235000013824 polyphenols Nutrition 0.000 description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 10
- 210000002374 sebum Anatomy 0.000 description 10
- 235000012239 silicon dioxide Nutrition 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 229920002261 Corn starch Polymers 0.000 description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 9
- 239000008120 corn starch Substances 0.000 description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 229940032147 starch Drugs 0.000 description 9
- 235000019698 starch Nutrition 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 8
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000004677 Nylon Substances 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 229920001778 nylon Polymers 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 150000002430 hydrocarbons Chemical class 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 7
- 229940098465 tincture Drugs 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 241000208690 Hamamelis Species 0.000 description 6
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 6
- 229960003237 betaine Drugs 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 239000000467 phytic acid Substances 0.000 description 6
- 235000002949 phytic acid Nutrition 0.000 description 6
- 229940068041 phytic acid Drugs 0.000 description 6
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 239000004926 polymethyl methacrylate Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- 241001474374 Blennius Species 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 235000010419 agar Nutrition 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 230000000593 degrading effect Effects 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 229960004889 salicylic acid Drugs 0.000 description 5
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 229920002050 silicone resin Polymers 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- 239000000375 suspending agent Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 4
- DISYHRKLFBBFAS-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropane-1,2-diol Chemical compound CC(C)C1CCC(C)(OCC(O)CO)CC1 DISYHRKLFBBFAS-UHFFFAOYSA-N 0.000 description 4
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 4
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 4
- 241000207199 Citrus Species 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 4
- 244000170916 Paeonia officinalis Species 0.000 description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 229960002684 aminocaproic acid Drugs 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 229940008396 carrot extract Drugs 0.000 description 4
- 229940119217 chamomile extract Drugs 0.000 description 4
- 235000020221 chamomile extract Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 239000000174 gluconic acid Substances 0.000 description 4
- 235000012208 gluconic acid Nutrition 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- JJOJFIHJIRWASH-UHFFFAOYSA-N icosanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- 239000003915 liquefied petroleum gas Substances 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 4
- 239000010445 mica Substances 0.000 description 4
- 229910052618 mica group Inorganic materials 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 239000004745 nonwoven fabric Substances 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 235000019477 peppermint oil Nutrition 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 229920000570 polyether Polymers 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 4
- 229960003471 retinol Drugs 0.000 description 4
- 235000020944 retinol Nutrition 0.000 description 4
- 239000011607 retinol Substances 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- HQHCYKULIHKCEB-UHFFFAOYSA-N tetradecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCC(O)=O HQHCYKULIHKCEB-UHFFFAOYSA-N 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- 150000003752 zinc compounds Chemical class 0.000 description 4
- 150000003755 zirconium compounds Chemical class 0.000 description 4
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 3
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 229940069521 aloe extract Drugs 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 229940037003 alum Drugs 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 229950004580 benzyl nicotinate Drugs 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 229960004926 chlorobutanol Drugs 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000010642 eucalyptus oil Substances 0.000 description 3
- 229940044949 eucalyptus oil Drugs 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229940094952 green tea extract Drugs 0.000 description 3
- 235000020688 green tea extract Nutrition 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 229940099690 malic acid Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 239000011164 primary particle Substances 0.000 description 3
- 239000001540 sodium lactate Substances 0.000 description 3
- 235000011088 sodium lactate Nutrition 0.000 description 3
- 229940005581 sodium lactate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 3
- 229960000401 tranexamic acid Drugs 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 235000019871 vegetable fat Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 239000004711 α-olefin Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 description 2
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 2
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- 108010087806 Carnosine Proteins 0.000 description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 244000019459 Cynara cardunculus Species 0.000 description 2
- 235000019106 Cynara scolymus Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 2
- 244000288377 Saxifraga stolonifera Species 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
- DDEDPQYNISJXLF-XTMYEIJHSA-N [(z)-4-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-3-benzoylsulfanylpent-3-enyl] benzoate;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N DDEDPQYNISJXLF-XTMYEIJHSA-N 0.000 description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 235000016520 artichoke thistle Nutrition 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 108010045569 atelocollagen Proteins 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 108010006161 conchiolin Proteins 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- HGOMLSWXJIICBL-UHFFFAOYSA-F dialuminum;zinc;tetrasulfate;tetracosahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[Al+3].[Zn+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O HGOMLSWXJIICBL-UHFFFAOYSA-F 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000004049 embossing Methods 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 229940002508 ginger extract Drugs 0.000 description 2
- 235000020708 ginger extract Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 229940108690 glucosyl hesperidin Drugs 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920005990 polystyrene resin Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 229940116317 potato starch Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- PFIPZKASKUWLHH-UHFFFAOYSA-N pyridoxamine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CN)=C1O PFIPZKASKUWLHH-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229940100486 rice starch Drugs 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 125000005625 siliconate group Chemical group 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940080313 sodium starch Drugs 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- XDLYMKFUPYZCMA-UHFFFAOYSA-M sodium;4-oct-1-enoxy-4-oxobutanoate Chemical compound [Na+].CCCCCCC=COC(=O)CCC([O-])=O XDLYMKFUPYZCMA-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 230000003813 thin hair Effects 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940100445 wheat starch Drugs 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- JWNQZUYANXGJGX-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) 2-hydroxypropanoate Chemical compound CC(C)C1CCC(C)(OC(=O)C(C)O)CC1 JWNQZUYANXGJGX-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- OAJLVMGLJZXSGX-CXGXMSGESA-L (2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4z,9z,14z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8 Chemical compound [Co+3].O[C@@H]1[C@H](O)[C@@H]([CH2-])O[C@H]1N1C2=NC=NC(N)=C2N=C1.O([C@H]1[C@H]([C@H](O[C@@H]1CO)N1C2=CC(C)=C(C)C=C2N=C1)O)P([O-])(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O OAJLVMGLJZXSGX-CXGXMSGESA-L 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- XSJPRWBZLUYOOI-UHFFFAOYSA-N (5-methyl-2-propan-2-ylcyclohexyl) 3-hydroxybutanoate Chemical compound CC(O)CC(=O)OC1CC(C)CCC1C(C)C XSJPRWBZLUYOOI-UHFFFAOYSA-N 0.000 description 1
- ABFCFYSYUKNFNA-NDNTWJFZSA-N (5R)-5-[(1S)-1,2-dihydroxyethyl]-5-(2,3-dihydroxypropyl)-3,4-dihydroxyfuran-2-one Chemical compound C(C(O)CO)[C@]1(C(=C(C(=O)O1)O)O)[C@@H](O)CO ABFCFYSYUKNFNA-NDNTWJFZSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- ZWNCJCPLPUBNCZ-UHFFFAOYSA-N 1,2-dimethoxyethane;hydrate Chemical compound O.COCCOC ZWNCJCPLPUBNCZ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical compound OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 description 1
- VUICSPKQAQGLBU-UHFFFAOYSA-N 1-(4-methylphenyl)ethyl pyridine-3-carboxylate Chemical compound C=1C=C(C)C=CC=1C(C)OC(=O)C1=CC=CN=C1 VUICSPKQAQGLBU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- NNOKXWHHOOMPPR-UHFFFAOYSA-N 1-ethenyl-1h-imidazol-1-ium;trichloride Chemical compound [Cl-].[Cl-].[Cl-].C=C[NH+]1C=CN=C1.C=C[NH+]1C=CN=C1.C=C[NH+]1C=CN=C1 NNOKXWHHOOMPPR-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- VFZRCLLDPCNXPS-UHFFFAOYSA-N 2,2,4,4,6,6,8,8,10,10-decamethyl-1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 VFZRCLLDPCNXPS-UHFFFAOYSA-N 0.000 description 1
- RNNHLXAEVKCLDG-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 RNNHLXAEVKCLDG-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- AERBHQYSUWNIDS-UHFFFAOYSA-N 2-(1-methyl-4,5-dihydroimidazol-1-ium-1-yl)ethanol Chemical compound OCC[N+]1(C)CCN=C1 AERBHQYSUWNIDS-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- RIAJTMUAPNIDSS-UHFFFAOYSA-N 3-aminopropan-1-ol;hydron;chloride Chemical compound Cl.NCCCO RIAJTMUAPNIDSS-UHFFFAOYSA-N 0.000 description 1
- YMTZCQOAGFRQHV-UHFFFAOYSA-N 3-methyl-4,5-dihydro-1,2-thiazole Chemical compound CC1=NSCC1 YMTZCQOAGFRQHV-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000009261 D 400 Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- ACEWLPOYLGNNHV-UHFFFAOYSA-N Ibuprofen piconol Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000226556 Leontopodium alpinum Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 239000004640 Melamine resin Substances 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- UAJFTICTIXLVSD-UHFFFAOYSA-N P(=O)(O)(O)O.OCCC[Na] Chemical compound P(=O)(O)(O)O.OCCC[Na] UAJFTICTIXLVSD-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-WCXIOVBPSA-N Pangamic acid Chemical compound CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RVSTWRHIGKXTLG-WCXIOVBPSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 240000009120 Phyllanthus emblica Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000013502 Pyrus japonica Nutrition 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- QEKBRBCVWVLFHH-QAKUKHITSA-L Tocopherol calcium succinate Chemical compound [Ca+2].[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C.[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C QEKBRBCVWVLFHH-QAKUKHITSA-L 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- RIQIJXOWVAHQES-UNAKLNRMSA-N Tocoretinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C RIQIJXOWVAHQES-UNAKLNRMSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- JDLSRXWHEBFHNC-UHFFFAOYSA-N Ufenamate Chemical compound CCCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 JDLSRXWHEBFHNC-UHFFFAOYSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- TXGSMRRWACWHFZ-MVIDNBQJSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-tris(pyridine-3-carbonyloxy)pentyl] pyridine-3-carboxylate Chemical compound O([C@@H](CN1C=2C(C(NC(=O)N=2)=O)=NC=2C=C(C(=CC=21)C)C)[C@H](OC(=O)C=1C=NC=CC=1)[C@@H](COC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 TXGSMRRWACWHFZ-MVIDNBQJSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- VVNANPHBTSDUIH-UHFFFAOYSA-N [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl acetate Chemical compound CC(=O)OCC1=CN=C(C)C(O)=C1CO VVNANPHBTSDUIH-UHFFFAOYSA-N 0.000 description 1
- GNKTZDSRQHMHLZ-UHFFFAOYSA-N [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] Chemical compound [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] GNKTZDSRQHMHLZ-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 1
- ASRPLWIDQZYBQK-UHFFFAOYSA-N acetic acid;pentanoic acid Chemical compound CC(O)=O.CCCCC(O)=O ASRPLWIDQZYBQK-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- XJKITIOIYQCXQR-SCUNHAKFSA-N all-trans-retinyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C XJKITIOIYQCXQR-SCUNHAKFSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940082880 azadirachta indica flower extract Drugs 0.000 description 1
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- IZJRISIINLJVBU-UHFFFAOYSA-N beta-Butoxyethyl nicotinate Chemical compound CCCCOCCOC(=O)C1=CC=CN=C1 IZJRISIINLJVBU-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CEBAWORGZDCFQS-UHFFFAOYSA-N butylcarbamic acid 1-iodoprop-1-yne Chemical compound C(#CC)I.C(CCC)NC(O)=O CEBAWORGZDCFQS-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 229920006319 cationized starch Polymers 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- JIHMVMRETUQLFD-UHFFFAOYSA-N cerium(3+);dioxido(oxo)silane Chemical compound [Ce+3].[Ce+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JIHMVMRETUQLFD-UHFFFAOYSA-N 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012611 container material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229940013640 flavin mononucleotide Drugs 0.000 description 1
- 239000011768 flavin mononucleotide Substances 0.000 description 1
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002305 glucosylceramides Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229950005954 ibuprofen piconol Drugs 0.000 description 1
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940073475 lysozyme hydrochloride Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WVJKHCGMRZGIJH-UHFFFAOYSA-N methanetriamine Chemical compound NC(N)N WVJKHCGMRZGIJH-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- 229940073663 methyl trimethicone Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- GGOIKTDZSHTAMC-UHFFFAOYSA-N octyl 3-(5-benzylidene-3-methoxy-2,4-dioxoimidazolidin-1-yl)-2-methoxypropanoate Chemical compound COC(C(=O)OCCCCCCCC)CN1C(N(C(C1=CC1=CC=CC=C1)=O)OC)=O GGOIKTDZSHTAMC-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002215 polytrimethylene terephthalate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 229940078492 ppg-17 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229940069774 quince extract Drugs 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- HWCHICTXVOMIIF-UHFFFAOYSA-M sodium;3-(dodecylamino)propanoate Chemical compound [Na+].CCCCCCCCCCCCNCCC([O-])=O HWCHICTXVOMIIF-UHFFFAOYSA-M 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 1
- 239000011678 thiamine pyrophosphate Substances 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical class CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229950010121 ufenamate Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- BLKLTTCUAPDQEG-UHFFFAOYSA-L zirconium(2+);chloride;hydroxide Chemical compound O[Zr]Cl BLKLTTCUAPDQEG-UHFFFAOYSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、頭皮用の制汗組成物に関する。 The present invention relates to an antiperspirant composition for the scalp.
体臭は、主に、皮脂と汗の混合物が皮膚常在菌により代謝され、脂肪酸などが産生されることにより生じる。そこで、従来から、腋臭や足臭を抑制するために、トリクロサン、塩化ベンザルコニウムなど、皮膚常在菌の増殖を抑制する殺菌成分を配合した外用組成物を用いることや、塩化アルミニウムなど、汗の発生を抑制する制汗成分を配合した外用組成物を用いることが知られている。 Body odor is mainly caused by a mixture of sebum and sweat being metabolized by skin-resident bacteria to produce fatty acids and the like. Therefore, conventionally, in order to suppress axillary odors and foot odors, triclosan, benzalkonium chloride and the like, using an external composition containing a bactericidal component that suppresses the growth of skin-resident bacteria, aluminum chloride, etc. It is known to use an external composition containing an antiperspirant component that suppresses the occurrence of
近年では、腋や足だけでなく、頭の汗や臭いに対する不快感を訴える人が増加している。頭皮における皮膚常在菌は、他の部位の皮膚とは異なり、スタフィロコッカス属細菌であるスタフィロコッカス カプティス(Staphylococcus captis)によって大半が構成されていることが知られており、かかる構成の相違は、頭皮の臭いが他の部位の皮膚から生じる臭いとは異なることの原因の一つではないかと考えられている(非特許文献1)。 In recent years, an increasing number of people are complaining not only of the armpits and feet but also of the sweat and smell of the head. It is known that most skin-resident bacteria on the scalp are composed of Staphylococcus captis, which is a bacterium belonging to the genus Staphylococcus, unlike the skin at other sites. Is considered to be one of the causes of the odor of the scalp being different from the odor generated from the skin of other parts (Non-Patent Document 1).
しかしながら、かかる頭皮の特性に着目した制汗組成物の研究開発は未だ充分には進んでいないのが現状である。 However, the present situation is that the research and development of antiperspirant compositions focusing on the properties of the scalp have not yet progressed sufficiently.
本発明者らは、当該現状に鑑みて鋭意検討を行った結果、次の課題に着目するに至った。皮膚常在菌は、皮膚表面の生態系バランスを保ち、バリア機能などを発揮するため、殺菌成分を含む外用組成物を頭皮に用いると、当該殺菌成分の種別によっては、頭皮の皮膚常在菌の生態系バランスを崩す恐れがあり、頭臭の原因となったり、バリア機能などを阻害することで、皮膚疾患などを生じる可能性がある。とりわけ、殺菌成分に加えて、汗の発生を抑制する制汗成分を含む外用組成物を頭皮に用いる場合、各成分の種別によっては、頭皮の皮膚常在菌に対して、当該殺菌成分を単独で用いる場合の殺菌効果よりも高い相加的な殺菌効果が生じる恐れがあり、頭皮の皮膚常在菌の生態系バランスを大きく崩す可能性がある。 As a result of intensive studies in view of the present situation, the present inventors have come to pay attention to the following problems. Since the skin resident bacteria maintain the ecological balance of the skin surface and exert the barrier function, etc., when an external composition containing a bactericidal component is used for the scalp, depending on the type of the bactericidal component, the skin resident bacteria of the scalp may be present. There is a risk that it may upset the ecological balance, and may cause head odors or block the barrier function, resulting in skin diseases. In particular, in addition to the bactericidal component, when using an external composition containing an antiperspirant component that suppresses the generation of sweat on the scalp, depending on the type of each component, against the skin resident bacteria of the scalp, the bactericidal component alone There is a possibility that an additive bactericidal effect that is higher than the bactericidal effect when used in 1. may be generated, and there is a possibility that the ecological balance of skin-resident bacteria of the scalp may be significantly disrupted.
また、外用組成物を頭皮に用いる場合、外用組成物が顔などに垂れ落ちる不快感や、髪型への影響などが懸念される。 In addition, when the external composition is used for the scalp, there is a concern that the external composition drips on the face or the like and may affect the hairstyle.
本発明は、前記課題に鑑みてなされたものであり、汗の発生を抑制すると共に、頭皮の皮膚常在菌に対する影響を抑えつつ、頭皮の臭いを抑制できる頭皮用制汗組成物を提供することを目的とする。 The present invention has been made in view of the above problems, and provides a scalp antiperspirant composition capable of suppressing the odor of the scalp while suppressing the generation of sweat and suppressing the effect on the skin resident bacteria of the scalp. The purpose is to
また、本発明は、前記課題に鑑みてなされたものであり、頭部からの垂れを抑制し、使用性の良好な頭皮用制汗組成物を提供することを他の目的とする。 In addition, the present invention has been made in view of the above problems, and another object thereof is to provide a scalp antiperspirant composition that suppresses dripping from the head and has good usability.
本発明者らは、前記課題に鑑みて鋭意検討を行った結果、フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、制汗成分とを含有する頭皮用制汗組成物を用いることにより、意外にも、汗の発生を抑制できると共に、頭皮の皮膚常在菌の生態系バランスを保持し易く、頭皮の臭いを抑制できるという顕著な効果を奏することを見出した。また、頭部からの垂れを抑制し、良好な使用性を有するという顕著な効果を奏することを見出し、本発明を完成するに至った。 The present inventors have conducted extensive studies in view of the above problems, and a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and at least one selected from the group consisting of zinc pyrithione. Surprisingly, by using an antiperspirant composition for the scalp containing an antiperspirant component, it is possible to unexpectedly suppress the generation of sweat, easily maintain the ecological balance of skin-resident bacteria of the scalp, and eliminate the odor of the scalp. It was found that the remarkable effect of being able to be suppressed is exhibited. Further, they have found that the present invention has a remarkable effect of suppressing dripping from the head and having good usability, and thus completed the present invention.
すなわち、本発明は、以下の各発明に関する。
[1](A)フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、(B)制汗成分とを含有する頭皮用制汗組成物。
[2]上記フェノール系殺菌成分が、イソプロピルメチルフェノール、トリクロサン、及びトリクロロカルバニリドからなる群より選択される少なくとも1種である、[1]に記載の頭皮用制汗組成物。
[3]上記第四級アンモニウム塩が、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、及び臭化セチルトリメチルアンモニウムからなる群より選択される少なくとも1種である、[1]又は[2]に記載の頭皮用制汗組成物。
[4]上記(B)成分が、クロルヒドロキシアルミニウム、塩化アルミニウム、アルミニウムジルコニウム複合塩、アラントインクロルヒドロキシアルミニウム、及びパラフェノールスルホン酸亜鉛からなる群より選択される少なくとも1種である、[1]〜[3]のいずれかに記載の頭皮用制汗組成物。
[5]さらに、(C)粉体を含有する、[1]〜[4]のいずれかに記載の頭皮用制汗組成物。
[6]さらに、(D)清涼成分を含有する、[1]〜[5]のいずれかに記載の頭皮用制汗組成物。
[7]頭皮の皮膚常在菌をコントロールするために用いられる、[1]〜[6]のいずれかに記載の頭皮用制汗組成物。
[8](A)フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、(B)制汗成分とを用いて、頭皮の皮膚常在菌をコントロールする方法。
That is, the present invention relates to the following inventions.
[1] A scalp containing at least one selected from the group consisting of (A) a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione; and (B) an antiperspirant component. Antiperspirant composition.
[2] The antiperspirant composition for scalp according to [1], wherein the phenolic bactericidal component is at least one selected from the group consisting of isopropylmethylphenol, triclosan, and trichlorocarbanilide.
[3] The quaternary ammonium salt is at least one selected from the group consisting of benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, cetyltrimethylammonium chloride, and cetyltrimethylammonium bromide, [1] Alternatively, the antiperspirant composition for scalp according to [2].
[4] The component (B) is at least one selected from the group consisting of chlorohydroxyaluminum, aluminum chloride, aluminum zirconium complex salt, allantoin chlorohydroxyaluminum, and zinc paraphenolsulfonate, [1] to The antiperspirant composition for scalp according to any one of [3].
[5] The antiperspirant composition for scalp according to any one of [1] to [4], further containing (C) powder.
[6] The antiperspirant composition for scalp according to any one of [1] to [5], which further contains (D) a cooling component.
[7] The antiperspirant composition for scalp according to any one of [1] to [6], which is used for controlling skin-resident bacteria on the scalp.
[8] Using (A) at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione, and (B) an antiperspirant component, A method for controlling skin-resident bacteria on the scalp.
本発明によれば、汗の発生を抑えると共に、頭皮の皮膚常在菌のバランスを保持し易く、頭皮の臭いを抑制できる頭皮用制汗組成物を提供することができる。 According to the present invention, it is possible to provide a scalp antiperspirant composition that can suppress the generation of sweat, can easily maintain the balance of skin-resident bacteria on the scalp, and can suppress the odor of the scalp.
また、本発明によれば、頭部からの垂れを抑えることによって、使用性の良好な頭皮用制汗組成物を提供することができる。 Further, according to the present invention, it is possible to provide a scalp antiperspirant composition having good usability by suppressing dripping from the head.
以下、本発明の実施の形態について詳しく説明する。ただし、本発明は以下の実施形態に限定されるものではない。 Hereinafter, embodiments of the present invention will be described in detail. However, the present invention is not limited to the following embodiments.
<頭皮用制汗組成物>
本発明は、(A)フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、(B)制汗成分とを含有する頭皮用制汗組成物であり、さらに、必要に応じて、(C)粉体、(D)清涼成分、又はその他の成分を含有するものである。
<Antiperspirant composition for scalp>
The present invention contains (A) at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione, and (B) an antiperspirant component. An antiperspirant composition for the scalp, which further contains (C) powder, (D) cooling component, or other components, if necessary.
<(A)成分>
(A)成分は特定の殺菌成分であり、フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選ばれる少なくとも1種である。フェノール系殺菌成分としては、例えば、イソプロピルメチルフェノール、トリクロサン、トリクロロカルバニリドなどが挙げられる。第四級アンモニウム塩としては、例えば、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、臭化セチルトリメチルアンモニウムなどが挙げられる。なかでも、本発明の効果をより一層高める観点から、好ましくは、イソプロピルメチルフェノール、ピロクトンオラミン、塩化ベンザルコニウム、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、臭化セチルトリメチルアンモニウム、グリチルレチン酸、ジンクピリチオンである。より好ましくは、イソプロピルメチルフェノール、ピロクトンオラミン、塩化ベンザルコニウム、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、臭化セチルトリメチルアンモニウム、グリチルレチン酸、ジンクピリチオンである。さらにより好ましくは、イソプロピルメチルフェノール、塩化ベンザルコニウム、臭化セチルトリメチルアンモニウム、グリチルレチン酸である。これらは、単独で又は2種以上を組み合わせてもよい。本発明の効果をより一層高める観点から、好ましい組み合わせは、例えば、イソプロピルメチルフェノールを少なくとも含み、ピロクトンオラミン、塩化ベンザルコニウム、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、臭化セチルトリメチルアンモニウム、グリチルレチン酸、ジンクピリチオンからなる群より選ばれる1種又は2種以上との組み合わせ、又は塩化ベンザルコニウムを少なくとも含み、ピロクトンオラミン、イソプロピルメチルフェノール、塩化セチルピリジニウム、塩化セチルトリメチルアンモニウム、臭化セチルトリメチルアンモニウム、グリチルレチン酸、ジンクピリチオンからなる群より選ばれる1種又は2種以上との組み合わせが好ましく、イソプロピルメチルフェノール及び臭化セチルトリメチルアンモニウム、イソプロピルメチルフェノール及びグリチルレチン酸、イソプロピルメチルフェノール及び塩化セチルピリジニウム、イソプロピルメチルフェノール及び塩化ベンザルコニウム、塩化ベンザルコニウム及び臭化セチルトリメチルアンモニウム、塩化ベンザルコニウム及びグリチルレチン酸、塩化ベンザルコニウム及び塩化セチルピリジニウムがより好ましく、イソプロピルメチルフェノール及び臭化セチルトリメチルアンモニウム、イソプロピルメチルフェノール及びグリチルレチン酸、イソプロピルメチルフェノール及び塩化ベンザルコニウム、塩化ベンザルコニウム及び臭化セチルトリメチルアンモニウム、塩化ベンザルコニウム及びグリチルレチン酸、塩化ベンザルコニウム及び塩化セチルピリジニウムがさらに好ましく、イソプロピルメチルフェノール及び塩化ベンザルコニウムがさらにより好ましい。
<(A) component>
The component (A) is a specific bactericidal component, and is at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione. Examples of the phenolic bactericidal component include isopropylmethylphenol, triclosan, trichlorocarbanilide and the like. Examples of the quaternary ammonium salt include benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide and the like. Among them, from the viewpoint of further enhancing the effect of the present invention, preferably, isopropylmethylphenol, piroctone olamine, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, glycyrrhetinic acid, zinc pyrithione. Is. More preferred are isopropylmethylphenol, piroctone olamine, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, glycyrrhetinic acid and zinc pyrithione. Even more preferred are isopropylmethylphenol, benzalkonium chloride, cetyltrimethylammonium bromide, and glycyrrhetinic acid. These may be used alone or in combination of two or more. From the viewpoint of further enhancing the effect of the present invention, preferred combinations include, for example, at least isopropylmethylphenol, piroctone olamine, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium chloride, cetyltrimethylammonium bromide, and glycyrrhetin. Acid, a combination with one or more selected from the group consisting of zinc pyrithione, or at least containing benzalkonium chloride, piroctone olamine, isopropylmethylphenol, cetylpyridinium chloride, cetyltrimethylammonium chloride, cetyltrimethyl bromide Ammonium, glycyrrhetinic acid, a combination with one or more selected from the group consisting of zinc pyrithione is preferred, isopropylmethylphenol and cetyltrimethylammonium bromide, isopropylmethylphenol and glycyrrhetinic acid, isopropylmethylphenol and cetylpyridinium chloride, isopropyl More preferred are methylphenol and benzalkonium chloride, benzalkonium chloride and cetyltrimethylammonium bromide, benzalkonium chloride and glycyrrhetinic acid, benzalkonium chloride and cetylpyridinium chloride, and isopropylmethylphenol and cetyltrimethylammonium bromide, isopropyl. Methylphenol and glycyrrhetinic acid, isopropylmethylphenol and benzalkonium chloride, benzalkonium chloride and cetyltrimethylammonium bromide, benzalkonium chloride and glycyrrhetinic acid, benzalkonium chloride and cetylpyridinium chloride are more preferred, and isopropylmethylphenol and Even more preferred is benzalkonium chloride.
(A)成分の含有量は、特に制限されないが、本発明の効果をより一層高める観点から、組成物全量に対して、例えば、0.001w/w%以上、好ましくは0.005w/w%以上、さらに好ましくは0.01w/w%以上である。また、(A)成分の含有量は、特に制限されないが、組成物全量に対して、例えば、0.2w/w%以下、好ましくは0.15w/w%以下、さらに好ましくは0.1w/w%以下である。 The content of the component (A) is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention, for example, 0.001 w/w% or more, preferably 0.005 w/w%, relative to the total amount of the composition. The above is more preferably 0.01 w/w% or more. The content of the component (A) is not particularly limited, but is, for example, 0.2 w/w% or less, preferably 0.15 w/w% or less, and more preferably 0.1 w/w based on the total amount of the composition. w% or less.
(A)成分を含有する頭皮用制汗組成物がエアゾール剤の場合、上記で例示した(A)成分の含有量は、噴射剤を除いた組成物の全量に対する含有量である。 When the scalp antiperspirant composition containing the component (A) is an aerosol, the content of the component (A) exemplified above is the content with respect to the total amount of the composition excluding the propellant.
<(B)成分>
(B)成分は、汗腺を収斂又は閉塞して汗の発生を抑制する制汗成分であり、例えば、アルミニウム化合物、ジルコニウム化合物、亜鉛化合物、アルミニウムとジルコニウム複合化合物、ミョウバンなどが挙げられる。アルミニウム化合物としては、例えば、塩化アルミニウム、硫酸アルミニウム、硫酸アルミニウムカリウム、硫酸アルミニウムアンモニウム、酢酸アルミニウム、クロルヒドロキシアルミニウム、アラントインクロルヒドロキシアルミニウム、ブロモヒドロキシアルミニウムなどが挙げられる。ジルコニウム化合物としては、例えば、酸化ジルコニウム、クロルヒドロキシジルコニウムなどが挙げられる。亜鉛化合物としては、例えば、パラフェノールスルホン酸亜鉛、酸化亜鉛などが挙げられる。アルミニウムとジルコニウム複合化合物としては、例えば、アルミニウムジルコニウム複合塩などが挙げられる。なかでも、本発明の効果をより一層高める観点から、好ましくは、クロルヒドロキシアルミニウム、アルミニウムジルコニウム複合塩、パラフェノールスルホン酸亜鉛、ミョウバンである。より好ましくは、クロルヒドロキシアルミニウム、パラフェノールスルホン酸亜鉛、ミョウバンである。さらにより好ましくは、クロルヒドロキシアルミニウム、パラフェノールスルホン酸亜鉛である。これらは、単独で又は2種以上を組み合わせてもよい。
<(B) component>
The component (B) is an antiperspirant component that converges or blocks the sweat glands to suppress the generation of sweat, and examples thereof include aluminum compounds, zirconium compounds, zinc compounds, aluminum and zirconium composite compounds, and alum. Examples of the aluminum compound include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, ammonium aluminum sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, bromohydroxyaluminum and the like. Examples of the zirconium compound include zirconium oxide and chlorohydroxyzirconium. Examples of the zinc compound include zinc paraphenol sulfonate and zinc oxide. Examples of the aluminum-zirconium composite compound include aluminum-zirconium composite salts. Among them, from the viewpoint of further enhancing the effect of the present invention, chlorohydroxyaluminum, aluminum zirconium complex salt, zinc paraphenolsulfonate, and alum are preferable. More preferred are chlorohydroxyaluminum, zinc paraphenolsulfonate, and alum. Even more preferably, they are chlorohydroxyaluminum and zinc paraphenolsulfonate. These may be used alone or in combination of two or more.
(B)成分の含有量は、特に制限されないが、本発明の効果をより一層高める観点から、組成物全量に対して、例えば、0.01w/w%以上、好ましくは0.05w/w%以上、さらに好ましくは0.1w/w%以上である。また、(B)制汗成分の含有量は、特に制限されないが、組成物全量に対して、例えば、30w/w%以下、好ましくは25w/w%以下、さらに好ましくは15w/w%以下である。 The content of the component (B) is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention, for example, 0.01 w/w% or more, preferably 0.05 w/w% with respect to the total amount of the composition. The above is more preferably 0.1 w/w% or more. The content of the (B) antiperspirant component is not particularly limited, but is, for example, 30 w/w% or less, preferably 25 w/w% or less, and more preferably 15 w/w% or less with respect to the total amount of the composition. is there.
(B)成分がアルミニウム化合物又はジルコニウム化合物の場合、その含有量は、特に制限されないが、本発明の効果をより一層高める観点から、組成物全量に対して、例えば、0.1w/w%以上、好ましくは0.5w/w%以上、さらに好ましくは1w/w%以上である。また、(B)成分がアルミニウム化合物又はジルコニウム化合物の場合、その含有量は、特に制限されないが、30w/w%以下、好ましくは25w/w%以下、さらに好ましくは15w/w%以下である。 When the component (B) is an aluminum compound or a zirconium compound, the content thereof is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention, for example, 0.1 w/w% or more based on the total amount of the composition. , Preferably 0.5 w/w% or more, more preferably 1 w/w% or more. When the component (B) is an aluminum compound or a zirconium compound, its content is not particularly limited, but is 30 w/w% or less, preferably 25 w/w% or less, more preferably 15 w/w% or less.
(B)成分が亜鉛化合物の場合、その含有量は、特に制限されないが、本発明の効果をより一層高める観点から、組成物全量に対して、例えば、0.01w/w%以上、好ましくは0.05w/w%以上、さらに好ましくは0.1w/w%以上である。また、(B)成分が亜鉛化合物の場合、その含有量は、特に制限されないが、組成物全量に対して、例えば、10w/w%以下、好ましくは5w/w%以下、さらに好ましくは3w/w%以下である。 When the component (B) is a zinc compound, its content is not particularly limited, but from the viewpoint of further enhancing the effects of the present invention, for example, 0.01 w/w% or more, preferably 0.01 w/w% or more, relative to the total amount of the composition. It is 0.05 w/w% or more, more preferably 0.1 w/w% or more. When the component (B) is a zinc compound, its content is not particularly limited, but is, for example, 10 w/w% or less, preferably 5 w/w% or less, and more preferably 3 w/w based on the total amount of the composition. w% or less.
(B)成分を含有する頭皮用制汗組成物がエアゾール剤の場合、その含有量は、特に制限されないが、本発明の効果をより一層高める観点から、噴射剤を除く組成物全量に対して、例えば、0.01w/w%以上、好ましくは0.05w/w%以上、さらに好ましくは0.1w/w%以上である。また、エアゾール剤における(B)成分の含有量は、特に制限されないが、噴射剤を除く組成物全量に対して、例えば、5w/w%以下、好ましくは4w/w%以下、さらに好ましくは3w/w%以下である。 When the scalp antiperspirant composition containing the component (B) is an aerosol agent, its content is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention, it is relative to the total amount of the composition excluding the propellant. For example, it is 0.01 w/w% or more, preferably 0.05 w/w% or more, and more preferably 0.1 w/w% or more. The content of the component (B) in the aerosol agent is not particularly limited, but is, for example, 5 w/w% or less, preferably 4 w/w% or less, and more preferably 3 w based on the total amount of the composition excluding the propellant. /W% or less.
(A)成分の含有量に対する(B)成分の含有量の比率については、特に制限されないが、本発明の効果をより一層高める観点から、例えば、(A)成分の含有量1重量部当たり、(B)成分の含有量が0.1〜30000重量部、好ましくは0.3〜5000重量部、より好ましくは1〜1500重量部である。 The ratio of the content of the component (B) to the content of the component (A) is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention, for example, per 1 part by weight of the content of the component (A), The content of the component (B) is 0.1 to 30000 parts by weight, preferably 0.3 to 5000 parts by weight, more preferably 1 to 1500 parts by weight.
<(C)粉体>
本発明の頭皮用制汗組成物の使用感を一層高めるなどの観点から、さらに(C)粉体を含むことが好ましい。(C)粉体としては、例えば、有機粉体、無機粉体などが挙げられる。有機粉体としては、例えば、トウモロコシデンプン、コメデンプン、タピオカデンプン、ジャガイモデンプン、コムギデンプン、シリコネート変性デンプン、オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウム、ポリウレタン、ナイロン末、ポリスチレン系樹脂、メチルシロキサン網状重合体、ポリメタクリル酸メチル系樹脂、メラミン樹脂、フェノール系樹脂、フッ素系樹脂、セルロース、シリコーン樹脂などが挙げられる。ポリウレタンとしては、例えば、(HDI/トリメチロールヘキシルラクトン)クロスポリマーなどが挙げられる。ポリメタクリル酸メチル系樹脂としては、例えば、メタクリル酸メチルクロスポリマー、ポリメタクリル酸メチルなどが挙げられる。シリコーン樹脂としては、例えば、(ジメチコン/ビニルジメチコン)クロスポリマー、(ジフェニルジメチコン/ビニルジフェニルジメチコン/シルセスキオキサン)クロスポリマー、(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマーなどが挙げられる。無機粉体としては、例えば、セリサイト、マイカ、カオリン、ベンガラ、クレー、ベントナイト、シリカ(無水ケイ酸・含水二酸化ケイ素)、タルク、又はこれらの表面をシリコーンなどで処理したものなどが挙げられる。なかでも、本発明の効果及び使用感をより一層高める観点から、好ましくは、トウモロコシデンプン、コメデンプン、タピオカデンプン、ジャガイモデンプン、コムギデンプン、シリコネート変性デンプン、オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウム、ポリウレタン、ナイロン末、ポリスチレン系樹脂、メチルシロキサン網状重合体、ポリメタクリル酸メチル系樹脂、セルロース、シリカ(無水ケイ酸・含水二酸化ケイ素)、タルク、シリコーン表面処理シリカ、シリコーン表面処理タルク、シリコーン樹脂である。より好ましくは、トウモロコシデンプン、オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウム、ポリウレタン、ナイロン末、メチルシロキサン網状重合体、ポリメタクリル酸メチル系樹脂、シリカ(無水ケイ酸・含水二酸化ケイ素)、タルク、シリコーン表面処理シリカ、シリコーン表面処理タルク、シリコーン樹脂である。さらにより好ましくは、トウモロコシデンプン、オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウム、(HDI/トリメチロールヘキシルラクトン)クロスポリマー、ナイロン末、メチルシロキサン網状重合体、メタクリル酸メチルクロスポリマー、ポリメタクリル酸メチル、シリカ(無水ケイ酸・含水二酸化ケイ素)、タルク、(ジメチコン/ビニルジメチコン)クロスポリマー、(ジフェニルジメチコン/ビニルジフェニルジメチコン/シルセスキオキサン)クロスポリマー、(ビニルジメチコン/メチコンシルセスキオキサン)クロスポリマー、シリコーン表面処理シリカ、シリコーン表面処理タルクである。特に好ましくは、トウモロコシデンプン、シリカ(無水ケイ酸・含水二酸化ケイ素)、タルクである。これらは、単独で又は2種以上を組み合わせてもよい。
<(C) powder>
From the viewpoint of further enhancing the usability of the scalp antiperspirant composition of the present invention, it is preferable to further contain (C) powder. Examples of the powder (C) include organic powder and inorganic powder. As the organic powder, for example, corn starch, rice starch, tapioca starch, potato starch, wheat starch, siliconate modified starch, sodium octenyl succinate starch, starch octenyl succinate aluminum, polyurethane, nylon powder, polystyrene resin, methylsiloxane reticulated heavy Examples thereof include coalesce, polymethylmethacrylate resin, melamine resin, phenol resin, fluorine resin, cellulose and silicone resin. Examples of polyurethane include (HDI/trimethylolhexyl lactone) crosspolymer. Examples of the polymethylmethacrylate-based resin include methylmethacrylate crosspolymer and polymethylmethacrylate. Examples of the silicone resin include (dimethicone/vinyl dimethicone) crosspolymer, (diphenyldimethicone/vinyldiphenyldimethicone/silsesquioxane) crosspolymer, (vinyldimethicone/methicone silsesquioxane) crosspolymer, and the like. Examples of the inorganic powder include sericite, mica, kaolin, red iron oxide, clay, bentonite, silica (anhydrous silicic acid/hydrous silicon dioxide), talc, and those whose surface is treated with silicone or the like. Among them, from the viewpoint of further enhancing the effect of the present invention and the feeling of use, corn starch, rice starch, tapioca starch, potato starch, wheat starch, siliconate modified starch, sodium octenyl succinate starch, starch octenyl succinate aluminum, and polyurethane are preferable. , Nylon powder, polystyrene resin, methylsiloxane network polymer, polymethylmethacrylate resin, cellulose, silica (silicic anhydride/hydrous silicon dioxide), talc, silicone surface treated silica, silicone surface treated talc, silicone resin. .. More preferably, corn starch, sodium starch octenyl succinate, aluminum starch octenyl succinate, polyurethane, nylon powder, methyl siloxane network polymer, polymethyl methacrylate resin, silica (silicic anhydride/hydrous silicon dioxide), talc, silicone surface Treated silica, silicone surface treated talc, and silicone resin. Even more preferably, corn starch, sodium starch octenyl succinate, starch aluminum octenyl succinate, (HDI/trimethylolhexyl lactone) crosspolymer, nylon powder, methylsiloxane network polymer, methylmethacrylate crosspolymer, polymethylmethacrylate, silica. (Silicic anhydride/hydrous silicon dioxide), talc, (dimethicone/vinyl dimethicone) crosspolymer, (diphenyldimethicone/vinyldiphenyldimethicone/silsesquioxane) crosspolymer, (vinyldimethicone/methicone silsesquioxane) crosspolymer, Silicone surface treated silica and silicone surface treated talc. Particularly preferred are corn starch, silica (silicic anhydride/hydrous silicon dioxide), and talc. These may be used alone or in combination of two or more.
(C)粉体の形状としては、特に制限されないが、球状、板状、粒状、針状などが挙げられる。 The shape of the (C) powder is not particularly limited, and examples thereof include spherical, plate-like, granular, and needle-like shapes.
(C)粉体の市販品としては、例えば、KSP−102、KSP−300、KMP−590、KMP−591、KSG−15(以上、信越化学工業社製)、SP−500(東レ社製)、ファインパール(住友化学工業社製)、テクポリマーSB、テクポリマーMB(以上、登録商標、積水化成品工業社製)、ファインパウダーSGP、ファインパウダーMP(以上、綜研化学社製)、トスパール145、トスパール2000B(以上、登録商標、東芝シリコーン社製)、BY29−129、トレフィル(登録商標、東レ・ダウコーニング・シリコーン社製)、マツモトマイクロスフェアーM(松本油脂製薬社製)、日本薬局方トウモロコシデンプンST−C(日澱化学社製)、トウモロコシデンプン(松谷化学工業社製)、ドライフロー PC(アクゾノーベル社製)、シリカビーズSB−300、SA−SB−300、SA−タルクJA−13R、SA−タルクJA−46R、SA−タルクJA−68R(以上、三好化成社製)、アエロジル200(登録商標、日本アエロジル社製)、タルクJA−46R、タルクMMR(以上、浅田製粉社製)、ガンツパールGM−0610、ガンツパールGMX−0810、ガンツパールGPA−550(以上、登録商標、アイカ工業社製)、PLASTIC POWDER D−400、PLASTIC POWDER D−400HP、PLASTIC POWDER D−800(以上、東色ピグメント社製)などが挙げられる。 (C) Commercially available powders include, for example, KSP-102, KSP-300, KMP-590, KMP-591, KSG-15 (all manufactured by Shin-Etsu Chemical Co., Ltd.), and SP-500 (manufactured by Toray). , Fine Pearl (Sumitomo Chemical Co., Ltd.), Techpolymer SB, Techpolymer MB (above, registered trademark, Sekisui Plastics Co., Ltd.), Fine Powder SGP, Fine Powder MP (above, Soken Chemical Industry Co., Ltd.), Tospearl 145 , Tospearl 2000B (above, registered trademark, manufactured by Toshiba Silicone Co., Ltd.), BY29-129, Trefil (registered trademark, manufactured by Toray Dow Corning Silicone Co., Ltd.), Matsumoto Microsphere M (manufactured by Matsumoto Yushi-Seiyaku Co., Ltd.), Japanese Pharmacopoeia Corn starch ST-C (manufactured by Nitto Chemical Co., Ltd.), corn starch (manufactured by Matsutani Chemical Co., Ltd.), dry flow PC (manufactured by Akzo Nobel), silica beads SB-300, SA-SB-300, SA-talc JA- 13R, SA-talc JA-46R, SA-talc JA-68R (above, manufactured by Miyoshi Kasei Co., Ltd.), Aerosil 200 (registered trademark, manufactured by Nippon Aerosil Co., Ltd.), talc JA-46R, talc MMR (above, manufactured by Asada Milling Co., Ltd. ), GANTZ PEARL GM-0610, GANTZ PEARL GMX-0810, GANTZ PEARL GPA-550 (above, registered trademark, manufactured by Aika Kogyo Co., Ltd.), PLASTIC POWDER D-400, PLASTIC POWDER D-400HP, PLASTIC POWDER D-800 (or more. Manufactured by Tohoku Pigment Co., Ltd.) and the like.
(C)粉体の含有量は、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、組成物全量に対して、例えば、0.1w/w%以上、好ましくは0.3w/w%以上、さらに好ましくは0.5w/w%以上である。また、(C)粉体の含有量は、特に制限されないが、組成物全量に対して、例えば、30w/w%以下、好ましくは20w/w%以下、さらに好ましくは10w/w%以下である。 The content of the (C) powder is not particularly limited, but from the viewpoint of further enhancing the effect of the present invention and the feeling of use, it is, for example, 0.1 w/w% or more, preferably 0. It is 3 w/w% or more, more preferably 0.5 w/w% or more. The content of the (C) powder is not particularly limited, but is, for example, 30 w/w% or less, preferably 20 w/w% or less, more preferably 10 w/w% or less with respect to the total amount of the composition. ..
(C)粉体の含有量は、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、剤型に応じて選択される。エアゾール剤の場合は、噴射剤を除く組成物全量に対して、例えば、1w/w%以上、好ましくは3w/w%以上、さらに好ましくは5w/w%以上である。また、(C)粉体の含有量は、特に制限されないが、噴射剤を除く組成物全量に対して、例えば、30w/w%以下、好ましくは25w/w%以下、さらに好ましくは20w/w%以下である。 The content of the (C) powder is not particularly limited, but is selected according to the dosage form from the viewpoint of further enhancing the effects and the feeling of use of the present invention. In the case of an aerosol agent, the amount is, for example, 1 w/w% or more, preferably 3 w/w% or more, more preferably 5 w/w% or more with respect to the total amount of the composition excluding the propellant. The content of the (C) powder is not particularly limited, but is, for example, 30 w/w% or less, preferably 25 w/w% or less, and more preferably 20 w/w with respect to the total amount of the composition excluding the propellant. % Or less.
(C)粉体の含有量は、特に制限されないが、ロールオンタイプやミストタイプなどの液剤、乳液、ゲル、クリームの場合は、組成物全量に対して、例えば、0.1w/w%以上、好ましくは0.3w/w%以上、さらに好ましくは0.5w/w%以上である。また、(C)粉体の含有量は、特に制限されないが、組成物全量に対して、例えば、20w/w%以下、好ましくは15w/w%以下、さらに好ましくは10w/w%以下である。 The content of the (C) powder is not particularly limited, but in the case of liquid agents such as roll-on type and mist type, emulsions, gels, and creams, for example, 0.1 w/w% or more based on the total amount of the composition, It is preferably 0.3 w/w% or more, more preferably 0.5 w/w% or more. The content of the (C) powder is not particularly limited, but is, for example, 20 w/w% or less, preferably 15 w/w% or less, and more preferably 10 w/w% or less with respect to the total amount of the composition. ..
(A)成分の含有量に対する(C)成分の含有量の比率については、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、例えば、(A)成分の含有量1重量部当たり、(C)成分の含有量が1〜30000重量部、好ましくは2〜5000重量部、より好ましくは5〜2000重量部である。 The ratio of the content of the component (C) to the content of the component (A) is not particularly limited, but from the viewpoint of further enhancing the effect and the feeling of use of the present invention, for example, the content of the component (A) is 1% by weight. The content of the component (C) is 1 to 30000 parts by weight, preferably 2 to 5000 parts by weight, and more preferably 5 to 2000 parts by weight per part.
(B)成分の含有量に対する(C)成分の含有量の比率については、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、例えば、(B)成分の含有量1重量部当たり、(C)成分の含有量が0.003〜3000重量部、好ましくは0.01〜500重量部、より好ましくは0.030〜200重量部である。 The ratio of the content of the component (C) to the content of the component (B) is not particularly limited, but from the viewpoint of further enhancing the effect and usability of the present invention, for example, the content of the component (B) is 1% by weight. The content of the component (C) is 0.003 to 3000 parts by weight, preferably 0.01 to 500 parts by weight, and more preferably 0.030 to 200 parts by weight per part.
(C)粉体の平均一次粒子径は、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、例えば、0.1μm以上、好ましくは1μm以上、さらに好ましくは5μm以上である。また、(C)粉体の平均一次粒子径は、特に制限されないが、例えば、30μm以下、好ましくは20μm以下、さらに好ましくは15μm以下である。前記平均一次粒子径は、レーザー回析散乱法により測定される。 The average primary particle diameter of the (C) powder is not particularly limited, but is, for example, 0.1 μm or more, preferably 1 μm or more, and more preferably 5 μm or more, from the viewpoint of further enhancing the effect and usability of the present invention. .. The average primary particle diameter of the (C) powder is not particularly limited, but is, for example, 30 μm or less, preferably 20 μm or less, more preferably 15 μm or less. The average primary particle size is measured by a laser diffraction scattering method.
<(D)清涼成分>
本発明の頭皮用制汗組成物の使用感を一層高めるなどの観点から、さらに(D)清涼成分を含むことが好ましい。(D)清涼成分としては、例えば、l−メントール、dl−メントール、l−メンチルグリセリルエーテル、l−メンチルラクテート、サリチル酸メンチル、メンチル3−ヒドロキシブチレート、メントキシプロパンジオール、dl−カンフル、クロロブタノール、ボルネオール、ゲラニオール、シネオール、リモネン、オイゲノール、ユーカリ油、ベルガモット油、ペパーミント油、クールミント油、スペアミント油、ウイキョウ油、ハッカ油、ケイヒ油、ローズ油、テレビン油などの精油などが挙げられる。なかでも、本発明の効果及び使用感をより一層高める観点から、好ましくは、l−メントール、l−メンチルグリセリルエーテル、l−メンチルラクテート、ユーカリ油、ハッカ油、クロロブタノールである。より好ましくは、l−メントール、l−メンチルグリセリルエーテル、ユーカリ油、ハッカ油である。これらは、単独で又は2種以上を組み合わせてもよい。
<(D) Cooling ingredient>
From the viewpoint of further enhancing the feeling of use of the scalp antiperspirant composition of the present invention, it is preferable to further contain (D) a cooling component. Examples of the cooling component (D) include l-menthol, dl-menthol, l-menthyl glyceryl ether, l-menthyl lactate, menthyl salicylate, menthyl 3-hydroxybutyrate, mentoxypropanediol, dl-camphor, chlorobutanol. , Essential oils such as borneol, geraniol, cineole, limonene, eugenol, eucalyptus oil, bergamot oil, peppermint oil, cool mint oil, spearmint oil, fennel oil, peppermint oil, cinnamon oil, rose oil, and turpentine oil. Of these, 1-menthol, 1-menthyl glyceryl ether, 1-menthyl lactate, eucalyptus oil, peppermint oil, and chlorobutanol are preferable from the viewpoint of further enhancing the effect and usability of the present invention. More preferred are l-menthol, l-menthyl glyceryl ether, eucalyptus oil and peppermint oil. These may be used alone or in combination of two or more.
(D)成分の含有量は、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、組成物全量に対して、例えば、0.01w/w%以上、好ましくは0.05w/w%以上、さらに好ましくは0.1w/w%以上である。また、(D)成分の含有量は、特に制限されないが、組成物全量に対して、例えば、5w/w%以下、好ましくは3w/w%以下、さらに好ましくは1w/w%以下である。 The content of the component (D) is not particularly limited, but from the viewpoint of further enhancing the effect and usability of the present invention, for example, 0.01 w/w% or more, preferably 0.05 w, relative to the total amount of the composition. /W% or more, more preferably 0.1 w/w% or more. The content of the component (D) is not particularly limited, but is, for example, 5 w/w% or less, preferably 3 w/w% or less, and more preferably 1 w/w% or less with respect to the total amount of the composition.
(D)成分を含む頭皮用制汗組成物がエアゾール剤の場合、上記で例示した(D)成分の含有量は、噴射剤を除いた組成物の全量に対する含有量である。 When the scalp antiperspirant composition containing the component (D) is an aerosol, the content of the component (D) exemplified above is the content with respect to the total amount of the composition excluding the propellant.
(A)成分の含有量に対する(D)成分の含有量の比率については、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、例えば、(A)成分の含有量1重量部当たり、(D)成分の含有量が0.05〜5000重量部、好ましくは0.3〜600重量部、より好ましくは1〜100重量部である。 The ratio of the content of the component (D) to the content of the component (A) is not particularly limited, but from the viewpoint of further enhancing the effect and the feeling of use of the present invention, for example, the content of the component (A) is 1 wt. The content of the component (D) is 0.05 to 5000 parts by weight, preferably 0.3 to 600 parts by weight, and more preferably 1 to 100 parts by weight per part.
(B)成分の含有量に対する(D)成分の含有量の比率については、特に制限されないが、本発明の効果及び使用感をより一層高める観点から、例えば、(B)成分の含有量1重量部当たり、(D)成分の含有量が0.0003〜500重量部、好ましくは0.002〜60重量部、より好ましくは0.006〜10重量部である。 The ratio of the content of the component (D) to the content of the component (B) is not particularly limited, but from the viewpoint of further enhancing the effect and the feeling of use of the present invention, for example, the content of the component (B) is 1% by weight. The content of the component (D) is 0.0003 to 500 parts by weight, preferably 0.002 to 60 parts by weight, and more preferably 0.006 to 10 parts by weight per part.
<その他の成分>
本発明の頭皮用制汗組成物は、本発明の効果を損なわない範囲で、上記(A)〜(D)成分以外の成分(その他の成分)を含有してもよい。例えば、基剤又は担体、界面活性剤、油分、増粘剤、防腐剤、酸化防止剤、保存剤、キレート剤、pH調整剤、安定化剤、溶解補助剤、緩衝剤、分散剤、着色剤、保湿成分、コンディショニング剤、血行促進剤、紫外線吸収成分、紫外線散乱成分、抗炎症剤、ビタミン類、有機酸、ペプチド又はその誘導体、アミノ酸又はその誘導体、洗浄成分、角質柔軟成分、細胞賦活化成分、老化防止成分、頭皮毛髪ケア成分、抗糖化成分などを配合することができる。その他の成分は、1種を単独で又は2種以上を組み合わせて使用できる。
<Other ingredients>
The antiperspirant composition for scalp of the present invention may contain components (other components) other than the components (A) to (D) described above within a range not impairing the effects of the present invention. For example, bases or carriers, surfactants, oils, thickeners, preservatives, antioxidants, preservatives, chelating agents, pH adjusters, stabilizers, solubilizers, buffers, dispersants, colorants. , Moisturizing ingredients, conditioning agents, blood circulation promoters, ultraviolet absorbing ingredients, ultraviolet scattering ingredients, anti-inflammatory agents, vitamins, organic acids, peptides or their derivatives, amino acids or their derivatives, washing ingredients, keratin softening ingredients, cell activating ingredients , An anti-aging component, a scalp hair care component, an anti-glycation component and the like can be added. The other components may be used alone or in combination of two or more.
<基剤又は担体>
基剤又は担体としては、例えば、流動パラフィン、スクワラン、ゲル化炭化水素(プラスチベースなど)、オゾケライト、α−オレフィンオリゴマー、軽質流動パラフィンなどの炭化水素;メチルポリシロキサン、架橋型メチルポリシロキサン、高重合メチルポリシロキサン、環状シリコーン、アルキル変性シリコーン、架橋型アルキル変性シリコーン、アミノ変性シリコーン、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、架橋型ポリエーテル変性シリコーン、架橋型アルキルポリエーテル変性シリコーン、シリコーン・アルキル鎖共変性ポリエーテル変性シリコーン、シリコーン・アルキル鎖共変性ポリグリセリン変性シリコーン、ポリエーテル変性分岐シリコーン、ポリグリセリン変性分岐シリコーン、アクリルシリコン、フェニル変性シリコーン、シリコーンレジンなどのシリコーン油;ポリエチレングリコール;ジオキサン;ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸セチル、イソノナン酸イソノニル、テトラ2−エチルヘキサン酸ペンタエリスリット、トリ(カプリル酸/カプリン酸)グリセリルなどのエステル類;エタノール、イソプロパノールなどの低級アルコール;ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテルなどのグリコールエーテル;ポリエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、グリセリン、イソプレングリコールなどの多価アルコール;水などの水系基剤などが挙げられる。
<Base or carrier>
Examples of the base or carrier include liquid paraffin, squalane, gelled hydrocarbon (plastibase, etc.), ozokerite, α-olefin oligomer, light liquid paraffin, and other hydrocarbons; methyl polysiloxane, cross-linked methyl polysiloxane, highly polymerized. Methyl polysiloxane, cyclic silicone, alkyl modified silicone, cross-linked alkyl modified silicone, amino modified silicone, polyether modified silicone, polyglycerin modified silicone, cross-linked polyether modified silicone, cross-linked alkyl polyether modified silicone, silicone/alkyl chain Silicone oils such as co-modified polyether-modified silicone, silicone/alkyl chain co-modified polyglycerin-modified silicone, polyether-modified branched silicone, polyglycerin-modified branched silicone, acrylic silicone, phenyl-modified silicone, silicone resin; polyethylene glycol; dioxane; myristin Esters such as isopropyl acid ester, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, isononyl isononanoate, pentaerythritol tetra-2-ethylhexanoate, glyceryl tri(caprylic/capric acid); lower grades such as ethanol and isopropanol Alcohols; glycol ethers such as diethylene glycol monomethyl ether and diethylene glycol monoethyl ether; polyhydric alcohols such as polyethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin and isoprene glycol; water-based bases such as water.
<界面活性剤>
界面活性剤としては、例えば、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ペンタ−2−エチルヘキシル酸ジグリセロールソルビタン、テトラ−2−エチルヘキシル酸ジグリセロールソルビタンなどのソルビタン脂肪酸エステル類;親油型モノステアリン酸グリセリルなどのグリセリン脂肪酸エステル類;モノステアリン酸プロピレングリコールなどのプロピレングリコール脂肪酸エステル類;ポリオキシエチレン硬化ヒマシ油40(HCO−40)、ポリオキシエチレン硬化ヒマシ油50(HCO−50)、ポリオキシエチレン硬化ヒマシ油60(HCO−60)、ポリオキシエチレン硬化ヒマシ油80(HCO−80)などの硬化ヒマシ油誘導体;モノラウリル酸ポリオキシエチレン(20)ソルビタン(ポリソルベート20)、モノラウリル酸ポリオキシエチレン(80)ソルビタン、モノステアリン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート60)、モノオレイン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート80)、イソステアリン酸ポリオキシエチレン(20)ソルビタンなどのポリオキシエチレンソルビタン脂肪酸エステル類;ポリオキシエチレンモノヤシ油脂肪酸グリセリルなどのポリオキシエチレン脂肪酸グリセリル類;グリセリンアルキルエーテル;アルキルグルコシド;ポリオキシエチレンセチルエーテルなどのポリオキシアルキレンアルキルエーテル;ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテルなどのポリオキシエチレンポリオキシプロピレンアルキルエーテル;ポリオキシエチレンラウリルアルコールエーテルなどの非イオン性界面活性剤;ステアリルアミン、オレイルアミンなどのアミン類;PEG−11メチルエーテルジメチコン、PEG−10ジメチコン、PEG/PPG−19/19ジメチコン、PEG−9ポリジメチルシロキシエチルジメチコンなどのポリエーテル変性シリコーン;ラウリルPEG−9ポリジメチルシロキシエチルジメチコン、セチルジメチコンコポリオールなどのポリエーテルアルキル共変性シリコーン;ポリグリセリン変性シリコーン;ポリグリセリンアルキル共変性シリコーン;架橋型シリコーンなどのシリコーン系界面活性剤;ラウリン酸塩、パルミチン酸塩、ココイルグルタミン酸塩、ヤシ油メチルアラニン塩、アシルメチルタウリン塩、ラウリル硫酸ナトリウムなどの高級アルキル硫酸エステル塩;POE−ラウリル硫酸ナトリウムなどのアルキルエーテル硫酸エステル塩;ラウロイルサルコシンナトリウムなどのN−アシルサルコシン酸;POE−ステアリルエーテルリン酸、セチルリン酸カリウム、リン酸セチル;ジ−2−エチルヘキシルスルホコハク酸ナトリウムなどのスルホコハク酸塩;アルキルベンゼンスルホン酸塩;高級脂肪酸エステル硫酸エステル塩;N−ラウロイルグルタミン酸モノナトリウム、N−ステアロイルグルタミン酸ジナトリウム、N−ミリストイル−L−グルタミン酸モノナトリウムなどのアシルグルタミン酸塩;POE−アルキルエーテルカルボン酸;POE−アルキルアリルエーテルカルボン酸塩;α−オレフィンスルホン酸塩;高級脂肪酸エステルスルホン酸塩などのアニオン性界面活性剤、ラウリルジアミノエチルグリシン塩;ヤシ油脂肪酸ベタイン塩;カルボベタイン;スルホベタイン;イミダゾリニウムベタイン;及びアミドベタインなどの両性界面活性剤、レシチン、水素添加レシチン、サポニン、サーファクチンナトリウム、胆汁酸などの天然由来の界面活性剤などが挙げられる。
<Surfactant>
Examples of the surfactant include sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, penta-2-ethylhexyl diglycerol sorbitan, and tetra-2-ethylhexyl diglycerol sorbitan. Sorbitan fatty acid esters; lipophilic glycerin fatty acid esters such as glyceryl monostearate; propylene glycol fatty acid esters such as propylene glycol monostearate; polyoxyethylene hydrogenated castor oil 40 (HCO-40), polyoxyethylene hydrogenated castor Hydrogenated castor oil derivatives such as oil 50 (HCO-50), polyoxyethylene hydrogenated castor oil 60 (HCO-60), polyoxyethylene hydrogenated castor oil 80 (HCO-80); polylauryl acid polyoxyethylene (20) sorbitan (Polysorbate 20), polyoxyethylene (80) sorbitan monolaurate, polyoxyethylene (20) sorbitan monostearate (polysorbate 60), polyoxyethylene (20) sorbitan monooleate (polysorbate 80), polyoxyisostearate Polyoxyethylene sorbitan fatty acid esters such as ethylene (20) sorbitan; polyoxyethylene fatty acid glyceryls such as polyoxyethylene monococonut oil fatty acid glyceryl; glycerin alkyl ethers; alkyl glucosides; polyoxyalkylene alkyls such as polyoxyethylene cetyl ether Ethers; polyoxyethylene polyoxypropylene decyl tetradecyl ether and other polyoxyethylene polyoxypropylene alkyl ethers; polyoxyethylene lauryl alcohol ether and other nonionic surfactants; stearylamine, oleylamine and other amines; PEG-11 Polyether-modified silicones such as methyl ether dimethicone, PEG-10 dimethicone, PEG/PPG-19/19 dimethicone, and PEG-9 polydimethylsiloxyethyl dimethicone; lauryl PEG-9 polydimethylsiloxyethyl dimethicone, cetyl dimethicone copolyol, and other poly Ether alkyl co-modified silicone; polyglycerin modified silicone; polyglycerin alkyl co-modified silicone; silicone type surfactant such as cross-linking silicone; laurate, palmitate, cocoyl glutamate, coconut oil methyl alanine salt, Acyl methyl taurine salt, higher alkyl sulfate ester salt such as sodium lauryl sulfate; POE-alkyl ether sulfate ester salt such as sodium lauryl sulfate; N-acyl sarcosinic acid such as sodium lauroyl sarcosine; POE-stearyl ether phosphate, potassium cetyl phosphate , Cetyl phosphate; sulfosuccinates such as sodium di-2-ethylhexyl sulfosuccinate; alkylbenzene sulfonates; higher fatty acid ester sulfate ester salts; monosodium N-lauroyl glutamate, disodium N-stearoyl glutamate, N-myristoyl-L -Acyl glutamate such as monosodium glutamate; POE-alkyl ether carboxylic acid; POE-alkyl allyl ether carboxylate; α-olefin sulfonate; anionic surfactant such as higher fatty acid ester sulfonate, lauryl diaminoethyl Glycine salt; coconut oil fatty acid betaine salt; carbobetaine; sulfobetaine; imidazolinium betaine; and amphoteric surfactants such as amidobetaine; naturally derived interfaces such as lecithin, hydrogenated lecithin, saponin, sodium surfactin, and bile acid. Activator etc. are mentioned.
<油分>
油分としては、例えば、天然動植物油脂類、ロウ類、炭化水素油、エステル油、シリコーン油、高級アルコール、高級脂肪酸などが挙げられる。
<Oil>
Examples of the oil component include natural animal and vegetable oils and fats, waxes, hydrocarbon oils, ester oils, silicone oils, higher alcohols, higher fatty acids and the like.
<天然動植物油脂類>
天然動植物油脂類としては、例えば、アボガド油、アマニ油、アーモンド油、オリーブ油、カカオ油、小麦胚芽油、ゴマ油、米胚芽油、米糠油、サフラワー油、大豆油、月見草油、ツバキ油、トウモロコシ油、ナタネ油、馬脂、パーシック油、パーム油、パーム核油、ヒマシ油、ヒマワリ油、豚脂、ブドウ油、ホホバ油、マカデミアナッツ油、ククイナッツ油、ヘーゼルナッツ油、綿実油、モクロウ、ヤシ油、硬化ヤシ油、落花生油、ラノリン、卵黄油、ローズヒップ油、シア脂などが挙げられる。
<Natural animal and vegetable oils and fats>
Examples of natural animal and vegetable oils and fats include avocado oil, linseed oil, almond oil, olive oil, cocoa oil, wheat germ oil, sesame oil, rice germ oil, rice bran oil, safflower oil, soybean oil, evening primrose oil, camellia oil, corn. Oil, rapeseed oil, horse fat, persic oil, palm oil, palm kernel oil, castor oil, sunflower oil, lard, grape oil, jojoba oil, macadamia nut oil, kukui nut oil, hazelnut oil, cottonseed oil, mokuro, palm oil, hardened oil Examples include coconut oil, peanut oil, lanolin, egg yolk oil, rosehip oil, and shea butter.
<ロウ類>
ロウ類としては、例えば、ホホバ油、ミウロウ、キャンデリラロウ、コメヌカロウ、綿ロウ、カルナウバロウ、ラノリンなどが挙げられる。
<wax>
Examples of the waxes include jojoba oil, miu wax, candelilla wax, rice bran wax, cotton wax, carnauba wax, lanolin and the like.
<炭化水素油>
炭化水素油としては、例えば、パラフィン系炭化水素、オレフィン系炭化水素が用いられ、例えば、スクワラン、スクワレン、セレシン、パラフィン、プリスタン、マイクロクリスタリンワックス、流動パラフィン、流動イソパラフィン、ワセリン、ポリブテン、ポリエチレン末、ゲル化炭化水素、オゾケライト、α−オレフィンオリゴマー、軽質流動パラフィン、軽質イソ流動パラフィンなどが挙げられる。
<Hydrocarbon oil>
As the hydrocarbon oil, for example, paraffin hydrocarbons, olefin hydrocarbons are used, for example, squalane, squalene, ceresin, paraffin, pristane, microcrystalline wax, liquid paraffin, liquid isoparaffin, petrolatum, polybutene, polyethylene powder, Examples thereof include gelled hydrocarbon, ozokerite, α-olefin oligomer, light liquid paraffin, and light iso liquid paraffin.
<エステル油>
エステル油としては、例えば、合成エステル類、高級アルコールと高級脂肪酸とのエステル類が用いられ、例えば、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、アジピン酸2−ヘキシルデシル、アジピン酸ジ−2−ヘプチルウンデシル、イソステアリン酸イソステアリル、トリイソステアリン酸トリメチロールプロパン、イソノナン酸イソノニル、イソノナン酸イソトリデシル、2−エチルヘキサン酸セチル、ジ−2−エチルヘキサン酸ネオペンチルグリコール、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリ2−エチルヘキサン酸グリセリル、テトラ−2−エチルヘキサン酸ペンタエリスリトール、オレイン酸エチル、オクタン酸セチル、オレイン酸オレイル、オレイン酸オクチルドデシル、オレイン酸デシル、ジカプリン酸ネオペンチルグリコール、コハク酸2−エチルヘキシル、ステアリン酸イソセチル、ステアリン酸ブチル、セバシン酸ジエチル、セバシン酸ジイソプロピル、セバシン酸ジ−2−エチルヘキシル、乳酸セチル、乳酸テトラデシル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、ミリスチン酸セチル、ミリスチン酸ミリスチル、パルミチン酸オクチル、パルミチン酸2−エチルヘキシル、パルミチン酸2−ヘキシルデシル、パルミチン酸イソプロピル、12−ヒドロキシステアリン酸コレステリル、オレイン酸フィトステリル、リンゴ酸ジイソステアリル、パラメトキシケイ皮酸エステル、テトラロジン酸ペンタエリスリット、シクロヘキサン−1,4−ジカルボン酸ビスエトキシジグリコール、コハク酸2−エチルヘキシル、コハク酸ジエトキシエチル、クエン酸トリエチル、(エイコサン二酸/テトラデカン二酸)デカグリセリルなどが挙げられる。
<Ester oil>
As the ester oil, for example, synthetic esters, esters of higher alcohols and higher fatty acids are used, and examples thereof include diisopropyl adipate, diisobutyl adipate, 2-hexyldecyl adipate, and di-2-heptylundecyl adipate. , Isostearyl isostearate, trimethylolpropane triisostearate, isononyl isononanoate, isotridecyl isononanoate, cetyl 2-ethylhexanoate, neopentyl glycol di-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, Glyceryl tri-2-ethylhexanoate, pentaerythritol tetra-2-ethylhexanoate, ethyl oleate, cetyl octanoate, oleyl oleate, octyldodecyl oleate, decyl oleate, neopentyl glycol dicaprate, 2-ethylhexyl succinate. , Isocetyl stearate, butyl stearate, diethyl sebacate, diisopropyl sebacate, di-2-ethylhexyl sebacate, cetyl lactate, tetradecyl lactate, isopropyl myristate, octyldodecyl myristate, myristyl myristate, myristyl myristate, palmitic acid Octyl, 2-ethylhexyl palmitate, 2-hexyldecyl palmitate, isopropyl palmitate, cholesteryl 12-hydroxystearate, phytosteryl oleate, diisostearyl malate, paramethoxycinnamic acid ester, pentaerythritol tetrarosinate, cyclohexane. Examples thereof include bisethoxydiglycol-1,4-dicarboxylate, 2-ethylhexyl succinate, diethoxyethyl succinate, triethyl citrate, and decaglyceryl (eicosanedioic acid/tetradecanedioic acid).
<シリコーン油>
シリコーン油としては、例えば、ジメチルポリシロキサン、高重合メチルポリシロキサン;メチルフェニルポリシロキサンなどのフェニル変性シリコーン;メチルハイドロジェンポリシロキサン;オクタメチルシクロテトラシロキサン、オクタメチルシクロペンタシロキサン、デカメチルシクロヘキサシロキサンなどの環状シリコーン;架橋型メチルポリシロキサン; メチルハイドロジェンポリシロキサン、メチルトリメチコン、ジメチコノール、ジメチコノールクロスポリマー;ステアロキシシリコーンなどの高級アルコキシ変性シリコーン;カプリリルメチコンなどのアルキル変性シリコーン;高級脂肪酸エステル変性シリコーンなどが挙げられる。
<Silicone oil>
Examples of the silicone oil include dimethylpolysiloxane, highly polymerized methylpolysiloxane; phenyl-modified silicone such as methylphenylpolysiloxane; methylhydrogenpolysiloxane; octamethylcyclotetrasiloxane, octamethylcyclopentasiloxane, decamethylcyclohexasiloxane. Cyclic silicones such as; Cross-linked methyl polysiloxane; Methyl hydrogen polysiloxane, methyl trimethicone, dimethiconol, dimethiconol crosspolymer; Higher alkoxy modified silicone such as stearoxy silicone; Alkyl modified silicone such as caprylyl methicone; Higher fatty acid ester modified Silicone etc. are mentioned.
<高級アルコール>
高級アルコールとしては、例えば、炭素数12〜22の高級アルコールやステロール類などが挙げられる。なかでも、ラウリルアルコール、ミリスチルアルコール、セタノール、セトステアリルアルコール、ステアリルアルコール、アラキルアルコール、ベヘニルアルコール、などの直鎖状飽和アルコール;オレイルアルコール、セラキルアルコールのような不飽和アルコール;又は、ヘキシルデカノール、イソステアリルアルコール、オクチルドデカノール、デシルテトラデカノール、ラノリンアルコール、イソステアリルグリセリルエーテルなどの分岐状アルコール、その他フィトステロール、コレステロールなどが挙げられる。なかでも好ましくは、セタノール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール、オレイルアルコール、イソステアリルアルコール、オクチルドデカノール、ラノリンアルコール、イソステアリルグリセリルエーテル、フィトステロール、コレステロールから選ばれる1種又は2種以上を組み合わせて使用することが好ましい。
<Higher alcohol>
Examples of higher alcohols include higher alcohols having 12 to 22 carbon atoms and sterols. Among them, linear saturated alcohols such as lauryl alcohol, myristyl alcohol, cetanol, cetostearyl alcohol, stearyl alcohol, aralkyl alcohol and behenyl alcohol; unsaturated alcohols such as oleyl alcohol and ceracyl alcohol; or hexyldecanol, iso Examples include branched alcohols such as stearyl alcohol, octyldodecanol, decyltetradecanol, lanolin alcohol, and isostearyl glyceryl ether; and phytosterols and cholesterol. Among them, preferably, one or more kinds selected from cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, oleyl alcohol, isostearyl alcohol, octyldodecanol, lanolin alcohol, isostearyl glyceryl ether, phytosterol, cholesterol are combined. Preference is given to using.
<高級脂肪酸>
高級脂肪酸としては、例えば、飽和又は不飽和の直鎖もしくは分岐鎖の炭素数12〜22の脂肪酸を用いることができ、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、マルガリン酸、アラキドン酸、又はベヘン酸などの直鎖状飽和脂肪酸;オレイン酸、リノール酸、リノレン酸、アラキドン酸、パルミトレイン酸、エイコサペンタエン酸、パクセン酸又はドコサヘキサエン酸などの不飽和脂肪酸;又は、イソステアリン酸又はラノリン脂肪酸などの分岐状脂肪酸、又は12−ヒドロキシステアリン酸などが挙げられる。なかでも好ましくは、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、リノール酸、リノレン酸、イソステアリン酸、ラノリン脂肪酸から選ばれる1種又は2種以上を組み合わせて使用することが好ましい。
<Higher fatty acid>
As the higher fatty acid, for example, a saturated or unsaturated linear or branched fatty acid having 12 to 22 carbon atoms can be used, and lauric acid, myristic acid, palmitic acid, stearic acid, margaric acid, arachidonic acid, or Linear saturated fatty acid such as behenic acid; unsaturated fatty acid such as oleic acid, linoleic acid, linolenic acid, arachidonic acid, palmitoleic acid, eicosapentaenoic acid, paxenoic acid or docosahexaenoic acid; or branched such as isostearic acid or lanolin fatty acid Fatty acid, 12-hydroxystearic acid and the like. Among them, preferably, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, isostearic acid, and lanolin fatty acid are used in combination or in combination of two or more. preferable.
<増粘剤>
増粘剤としては、例えば、グアーガム、ローカストビーンガム、カラギーナン、キサンタンガム、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、疎水化ヒドロキシプロピルメチルセルロース、ペクチン、プルラン、寒天、アルギン酸ナトリウム、アルギン酸プロピレングリコール、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸メタクリル酸アルキル共重合体、ポリエチレングリコール、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマーなどが挙げられる。
<Thickener>
Examples of the thickener include guar gum, locust bean gum, carrageenan, xanthan gum, carboxymethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydrophobized hydroxypropylmethylcellulose, pectin, pullulan, agar, sodium alginate, Propylene glycol alginate, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, alkyl methacrylate acrylate copolymer, polyethylene glycol, (hydroxyethyl acrylate/acryloyldimethyltaurine Na) copolymer, (acryloyldimethyltaurine ammonium/vinylpyrrolidone) copolymer, etc. Is mentioned.
<酸化防止剤>
酸化防止剤としては、例えば、ジブチルヒドロキシトルエン(BHT)、ブチルヒドロキシアニソール、ソルビン酸、亜硫酸ナトリウム、アスコルビン酸、エリソルビン酸、L−システイン塩酸塩、トコフェロール、酢酸トコフェロール、などが挙げられる。
<Antioxidant>
Examples of the antioxidant include dibutylhydroxytoluene (BHT), butylhydroxyanisole, sorbic acid, sodium sulfite, ascorbic acid, erythorbic acid, L-cysteine hydrochloride, tocopherol, and tocopherol acetate.
<保存剤又は防腐剤>
保存剤又は防腐剤としては、例えば、安息香酸、安息香酸ナトリウム、デヒドロ酢酸、デヒドロ酢酸ナトリウム、パラオキシ安息香酸イソブチル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸ブチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ベンジル、パラオキシ安息香酸メチル、フェノキシエタノール、ソルビン酸、クロロブタノール、ベンジルアルコール、フェネチルアルコール、カプリルヒドロキサム酸、メチルイソチアゾリン、ブチルカルバミン酸ヨウ化プロピニルなどが挙げられる。
<Preservative or preservative>
Examples of the preservative or preservative include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, butyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and paraoxybenzoate. Examples thereof include benzyl benzoate, methyl paraoxybenzoate, phenoxyethanol, sorbic acid, chlorobutanol, benzyl alcohol, phenethyl alcohol, capryl hydroxamic acid, methylisothiazoline and butylcarbamate propynyl iodide.
<キレート剤>
キレート剤としては、例えば、EDTA・2ナトリウム塩、EDTA・カルシウム・2ナトリウム塩、ポリリン酸、メタリン酸などが挙げられる。
<Chelating agent>
Examples of the chelating agent include EDTA.disodium salt, EDTA.calcium.disodium salt, polyphosphoric acid, metaphosphoric acid and the like.
<pH調整剤>
pH調整剤としては、例えば、無機酸(塩酸、硫酸など)、有機酸(乳酸、乳酸ナトリウム、クエン酸、クエン酸ナトリウム、コハク酸、コハク酸ナトリウムなど)、無機塩基(水酸化カリウム、水酸化ナトリウムなど)、有機塩基(トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミンなど)などが挙げられる。
<pH adjuster>
Examples of pH adjusters include inorganic acids (hydrochloric acid, sulfuric acid, etc.), organic acids (lactic acid, sodium lactate, citric acid, sodium citrate, succinic acid, sodium succinate, etc.), inorganic bases (potassium hydroxide, hydroxide). Sodium), organic bases (triethanolamine, diisopropanolamine, triisopropanolamine, etc.) and the like.
<安定化剤>
安定化剤としては、例えば、ポリアクリル酸ナトリウム、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソールなどが挙げられる。
<Stabilizer>
Examples of the stabilizer include sodium polyacrylate, dibutylhydroxytoluene, butylhydroxyanisole and the like.
<溶解補助剤>
溶解補助剤としては、例えば、ポリエチレングリコール、プロピレングリコールなどの多価アルコール、D−マンニトールなどの糖アルコール、安息香酸ベンジル、エタノール、イソプロパノール、トリスアミノメタン、コレステロール、トリエタノールアミン、炭酸ナトリウム、クエン酸ナトリウムなどが挙げられる。
<Dissolution aid>
Examples of the solubilizing agent include polyhydric alcohols such as polyethylene glycol and propylene glycol, sugar alcohols such as D-mannitol, benzyl benzoate, ethanol, isopropanol, trisaminomethane, cholesterol, triethanolamine, sodium carbonate and citric acid. Examples include sodium.
<緩衝剤>
緩衝剤としては、例えば、リン酸塩、酢酸塩、炭酸塩、クエン酸塩などの緩衝液などが挙げられる。
<Buffer>
Examples of the buffering agent include buffer solutions of phosphate, acetate, carbonate, citrate and the like.
<分散剤>
分散剤としては、例えば、ピロリン酸ナトリウム、ヘキサメタリン酸ナトリウム、ポリビニルアルコール、ポリビニルピロリドン、メチルビニルエーテル/無水マレイン酸架橋コポリマー、有機酸などが挙げられる。
<Dispersant>
Examples of the dispersant include sodium pyrophosphate, sodium hexametaphosphate, polyvinyl alcohol, polyvinylpyrrolidone, methyl vinyl ether/maleic anhydride cross-linked copolymer, organic acid and the like.
<着色剤>
着色剤としては、例えば、無機顔料、天然色素などが挙げられる。
<Colorant>
Examples of the colorant include inorganic pigments and natural dyes.
<保湿成分>
保湿成分としては、例えば、グリセリン、1,3−ブチレングリコール、プロピレングリコール、ポリエチレングリコール、ジグリセリンなどの多価アルコール;PEG/PPG/ポリブチレングリコール−8/6/3グリセリン、PPG−17ブテス−17、PPG−24グリセレス−24などの多価アルコール誘導体;グリコシルトレハロース、トレハロース、ソルビトール、キシリトール、オリゴ糖、グリセリルグルコシドなどの糖類;ヒアルロン酸類(ヒアルロン酸ナトリウム、低分子ヒアルロン酸、ヒアルロン酸亜鉛、アセチル化ヒアルロン酸、カチオン化ヒアルロン酸などのヒアルロン酸誘導体)、ヘパリン類似物質、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、ケラチン、キチン、キトサンなどの高分子化合物;グリシン、アスパラギン酸、アルギニンなどのアミノ酸及びその誘導体;乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウムなどの天然保湿因子;セラミド、グルコシルセラミド、コレステロール、フィトステロール、コレステロール誘導体リン脂質などの脂質;カミツレエキス、ハマメリスエキス、チャエキス、緑茶エキス、シソエキス、セージエキス、海藻エキス、ノイバラエキス、シャクヤクエキス、ヨモギエキス、アロエエキス、オウゴンエキス、カッコンエキスなどの植物抽出エキスなどが挙げられる。
<Moisturizing ingredient>
Examples of the moisturizing component include polyhydric alcohols such as glycerin, 1,3-butylene glycol, propylene glycol, polyethylene glycol and diglycerin; PEG/PPG/polybutylene glycol-8/6/3 glycerin, PPG-17 buttes- 17, polyhydric alcohol derivatives such as PPG-24 glycereth-24; sugars such as glycosyltrehalose, trehalose, sorbitol, xylitol, oligosaccharides, glyceryl glucoside; hyaluronic acids (sodium hyaluronate, low molecular weight hyaluronic acid, zinc hyaluronate, acetyl) Hyaluronic acid, cationized hyaluronic acid and other hyaluronic acid derivatives), heparin analogues, macromolecular compounds such as sodium chondroitin sulfate, collagen, elastin, keratin, chitin, chitosan; amino acids such as glycine, aspartic acid, arginine and their derivatives Natural moisturizing factors such as sodium lactate, urea, sodium pyrrolidonecarboxylate; lipids such as ceramide, glucosylceramide, cholesterol, phytosterol, cholesterol derivative phospholipids; chamomile extract, hamamelis extract, tea extract, green tea extract, perilla extract, sage extract, seaweed Examples thereof include plant extracts such as extracts, Neubara extract, peony extract, mugwort extract, aloe extract, sardine extract, and cucumber extract.
<コンディショニング剤>
コンディショニング剤としては、例えば、カチオン化セルロース、カチオン化澱粉、カチオン化フェヌグリークガム、カチオン化グアーガム、カチオン化タラガム、カチオン化ローカストビーンガム、カチオン化キサンタンガム、ジアリル四級アンモニウム塩/アクリルアミド共重合物、ポリクオタニウム、ビニルイミダゾリウムトリクロライド/ビニルピロリドン共重合体、ヒドロキシエチルセルロース/ジメチルジアリルアンモニウムクロライド共重合体、ビニルピロリドン/四級化ジメチルアミノエチルメタクリレート共重合体、ポリビニルピロリドン/アルキルアミノアクリレート共重合体、ポリビニルピロリドン/アルキルアミノアクリレート/ビニルカプロラクタム共重合体、ビニルピロリドン/メタクリルアミドプロピル塩化トリメチルアンモニウム共重合体、アルキルアクリルアミド/アクリレート/アルキルアミノアルキルアクリルアミド/ポリエチレングリコールメタクリレート共重合体、アジピン酸/ジメチルアミノヒドロキシプロピルエチレントリアミン共重合体などが挙げられる。
<Conditioning agent>
Examples of the conditioning agent include cationized cellulose, cationized starch, cationized fenugreek gum, cationized guar gum, cationized tara gum, cationized locust bean gum, cationized xanthan gum, diallyl quaternary ammonium salt/acrylamide copolymer, polyquaternium. , Vinylimidazolium trichloride/vinylpyrrolidone copolymer, hydroxyethylcellulose/dimethyldiallylammonium chloride copolymer, vinylpyrrolidone/quaternized dimethylaminoethylmethacrylate copolymer, polyvinylpyrrolidone/alkylaminoacrylate copolymer, polyvinylpyrrolidone /Alkylaminoacrylate/vinylcaprolactam copolymer, vinylpyrrolidone/methacrylamidopropyltrimethylammonium chloride copolymer, alkylacrylamide/acrylate/alkylaminoalkylacrylamide/polyethylene glycol methacrylate copolymer, adipic acid/dimethylaminohydroxypropylethylenetriamine Examples thereof include copolymers.
<血行促進剤>
血行促進剤としては、例えば、アセチルコリン、イクタモール、カフェイン、カプサイシン、カンタリスチンキ、ガンマーオリザノール、ショオウキョウチンキ、ジンゲロン、セファランチン、センブリエキス、タンニン酸、トウガラシチンキ、トラゾリン、グルコシルヘスペリジン、ヘスペリジン、酢酸dl−α−トコフェロール、ニコチン酸トコフェロール、ニコチン酸ベンジルエステル、オタネニンジンエキス、カロットエキス、チョウジエキス、チンピエキス、トウキエキス、ショウキョウエキス、ジオウエキス、トウキセンカエキス、ボタンエキス、ニンジンエキス、オトギリソウエキス、ケイ皮エキスなどが挙げられる。
<Blood circulation promoter>
Examples of the blood circulation promoter include acetylcholine, ictamol, caffeine, capsaicin, cantharisin tincture, gamma oryzanol, ginger oriental tincture, zingerone, cepharantin, cembly extract, tannic acid, capsicum tincture, trazoline, glucosyl hesperidin, hesperidin, dl acetate. -Α-tocopherol, nicotinic acid tocopherol, nicotinic acid benzyl ester, ginseng extract, carrot extract, clove extract, chimpanzee extract, Japanese quince extract, ginger extract, ginger extract, ginseng extract, button extract, carrot extract, hypericum extract, cinnamon extract. And so on.
<紫外線吸収成分>
紫外線吸収成分としては、オクチルトリアゾン、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、パラメトキシケイ皮酸2−エチルヘキシル、t−ブチルメトキシジベンゾイルメタン、フェニルベンズイミダゾールスルホン酸、メトキシケイヒ酸オクチル、メトキシケイヒ酸エチルヘキシル、オクトクリレン、ジメチコジエチルベンザルマロネートなどが挙げられる。
<Ultraviolet absorbing component>
As the ultraviolet absorbing component, octyltriazone, hexyl diethylaminohydroxybenzoylbenzoate, octyl dimethoxybenzylidenedioxoimidazolidinepropionate, 2-ethylhexyl paramethoxycinnamate, t-butylmethoxydibenzoylmethane, phenylbenzimidazole sulfonic acid, Examples include octyl methoxycinnamate, ethylhexyl methoxycinnamate, octocrylene, dimethicodiethylbenzalmalonate, and the like.
<紫外線散乱成分>
紫外線散乱成分としては、例えば、含水ケイ酸、ケイ酸亜鉛、ケイ酸セリウム、ケイ酸チタン、酸化亜鉛、酸化ジルコニウム、酸化セリウム、酸化チタン、酸化鉄、無水ケイ酸などの無機化合物、それらの無機化合物を含水ケイ酸、水酸化アルミニウム、マイカやタルクなどの無機粉体で被覆したり、ポリアミド、ポリエチレン、ポリエステル、ポリスチレン、ナイロンなどの樹脂粉体に複合化したもの、さらにシリコーン油や脂肪酸アルミニウム塩などで処理したものなどが挙げられる。
<Ultraviolet scattering component>
As the ultraviolet scattering component, for example, hydrous silicic acid, zinc silicate, cerium silicate, titanium silicate, zinc oxide, zirconium oxide, cerium oxide, titanium oxide, iron oxide, inorganic compounds such as anhydrous silicic acid, their inorganic Compounds coated with hydrous silicic acid, aluminum hydroxide, inorganic powders such as mica and talc, or compounded with resin powders such as polyamide, polyethylene, polyester, polystyrene and nylon, and silicone oil and fatty acid aluminum salts. And the like.
<抗炎症剤>
抗炎症剤としては、例えば、ステロイド系抗炎症剤、又は非ステロイド系抗炎症剤のいずれも用いることができる。例えば、アラントイン、グリチルリチン酸又はその塩、吉草酸酢酸プロドニゾロン又はヒドロコルチゾンなどのステロイド類、ウフェナマート、ブフェキサマク、イブプロフェンピコノール、サリチル酸グリコール、トラネキサム酸が例示されるが、これに限定されない。さらに、例えば、インドメタシン、ジクロフェナク、ピロキシカム、イプシロン−アミノカプロン酸、ベルベリン、リゾチーム、アズレン、及びそれらの薬学的に許容される塩、植物由来成分(例えば、コンフリー、オウレン、ドクダミ、クロレラ、エチナシ葉、ユキノシタ、ヒキオコシ、オウゴン、カワラヨモギ、シソ、ショウブ根、セージ、セイヨウサンザシ、チョウジ、ニーム葉、ヒオウギ、モモ葉、サクラ葉、アーティチョーク、海藻、チャなどの抽出物に由来する成分)が例示される。好ましくは、アラントイン、トラネキサム酸、グリチルリチン酸ジカリウム、グリチルリチン酸モノアンモニウム、イプシロン−アミノカプロン酸、アズレン及びその誘導体から選ばれる1種又は2種以上との組み合わせ、さらに好ましくは、アラントイン、トラネキサム酸、グリチルリチン酸ジカリウム、イプシロン−アミノカプロン酸から選ばれる1種又は2種以上との組み合わせである。
<Anti-inflammatory agent>
As the anti-inflammatory agent, for example, either a steroidal anti-inflammatory agent or a non-steroidal anti-inflammatory agent can be used. Examples thereof include, but are not limited to, allantoin, glycyrrhizic acid or a salt thereof, steroids such as prodnisolone valerate acetate or hydrocortisone, ufenamate, bufexamac, ibuprofen piconol, glycol salicylate, and tranexamic acid. Furthermore, for example, indomethacin, diclofenac, piroxicam, epsilon-aminocaproic acid, berberine, lysozyme, azulene, and pharmaceutically acceptable salts thereof, plant-derived components (e.g., comfrey, auren, dokudami, chlorella, ethnic leaf, (Ingredients derived from extracts such as Yukinoshita, Hikiokoshi, Ogon, Kawamura Artemisia, Perilla, ginseng root, sage, hawthorn, clove, neem leaf, Hyogi, peach leaf, cherry leaf, artichoke, seaweed, tea, etc.) are exemplified. Preferably, allantoin, tranexamic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, epsilon-aminocaproic acid, azulene, and a combination thereof with one or more selected from derivatives thereof, more preferably allantoin, tranexamic acid, glycyrrhizic acid It is a combination of one or more selected from dipotassium and epsilon-aminocaproic acid.
<ビタミン類>
ビタミン類としては、例えば、dl−α−トコフェロール、酢酸dl−α−トコフェロール、コハク酸dl−α−トコフェロール、コハク酸dl−α−トコフェロールカルシウムなどのビタミンE類;リボフラビン、フラビンモノヌクレオチド、フラビンアデニンジヌクレオチド、リボフラビン酪酸エステル、リボフラビンテトラ酪酸エステル、リボフラビン5'−リン酸エステルナトリウム、リボフラビンテトラニコチン酸エステルなどのビタミンB2類;ニコチン酸、ニコチン酸アミド、ニコチン酸dl−α−トコフェロール、ニコチン酸ベンジル、ニコチン酸メチル、ニコチン酸β−ブトキシエチル、ニコチン酸1−(4−メチルフェニル)エチルなどのニコチン酸類;アスコルビゲン−A、アスコルビン酸ステアリン酸エステル、アスコルビン酸パルミチン酸エステル、ジパルミチン酸L−アスコルビル、テトライソパルミチン酸アスコルビル、パルミチン酸アスコルビルリン酸3ナトリウム、アスコルビン酸、アスコルビン酸ナトリウム、デヒドロアスコルビン酸、アスコルビン酸リン酸エステルナトリウム、アスコルビン酸リン酸エステルマグネシウム、アスコルビン酸グルコシド、2−O−エチルアスコルビン酸、3−O−エチルアスコルビン酸、グリセリルアスコルビン酸、ビスグリセリルアスコルビン酸、アルキルグリセリルアスコルビン酸などのビタミンC類;メチルヘスペリジン、エルゴカルシフェロール、コレカルシフェロールなどのビタミンD類;フィロキノン、ファルノキノンなどのビタミンK類、γ−オリザノール、ジベンゾイルチアミン、ジベンゾイルチアミン塩酸塩;チアミン、及びそれらの塩(例えば、ジベンゾイルチアミン塩酸塩、チアミン塩酸塩、チアミンニリン酸塩、)などのビタミンB1類;塩酸ピリドキシン、酢酸ピリドキシン、塩酸ピリドキサール、5'−リン酸ピリドキサール、塩酸ピリドキサミンなどのビタミンB6類;シアノコバラミン、ヒドロキソコバラミン、デオキシアデノシルコバラミンなどのビタミンB12類;葉酸、プテロイルグルタミン酸などの葉酸類;レチノール、酢酸レチノール、パルミチン酸レチノール、プロピオン酸レチノール、リノール酸レチノールなどのレチノール誘導体、レチナール、レチノイン酸、トコフェリルレチノエートなどのビタミンA類;カロテン、リコピン、ゼアキサンチン、クリプトキサンチン、エキネノンなどのプロビタミンA類;パントテン酸、パントテン酸カルシウム、パントテニルアルコール(パンテノール)、D−パンテサイン、D−パンテチン、補酵素A、パントテニルエチルエーテルなどのパントテン酸類;ビオチン、ビオチシンなどのビオチン類;カルニチン、フェルラ酸、α−リポ酸、オロット酸、γ−オリザノール、ピロロキノリンキノン、グルコシルヘスペリジン、ユビキノンなどのビタミン様作用因子などが挙げられる。
<Vitamins>
Examples of vitamins include vitamin Es such as dl-α-tocopherol, dl-α-tocopherol acetate acetate, dl-α-tocopherol succinate, dl-α-tocopherol calcium succinate; riboflavin, flavin mononucleotide, flavin adenine. Vitamin B2s such as dinucleotides, riboflavin butyrate, riboflavin tetrabutyrate, riboflavin 5'-phosphate sodium salt, riboflavin tetranicotinate; nicotinic acid, nicotinic acid amide, nicotinic acid dl-α-tocopherol, benzyl nicotinate , Nicotinic acid such as methyl nicotinate, β-butoxyethyl nicotinate, and 1-(4-methylphenyl)ethyl nicotinate; ascorbogen-A, ascorbyl stearate, ascorbyl palmitate, dipalmitate L-ascorbyl. , Ascorbyl tetraisopalmitate, ascorbyl palmitate trisodium phosphate, ascorbic acid, sodium ascorbate, dehydroascorbic acid, sodium ascorbate phosphate, magnesium ascorbate phosphate, ascorbate glucoside, 2-O-ethylascorbine Vitamin Cs such as acids, 3-O-ethylascorbic acid, glycerylascorbic acid, bisglycerylascorbic acid, alkylglycerylascorbic acid; vitamin Ds such as methylhesperidin, ergocalciferol, cholecalciferol; phylloquinone, farnoquinone, etc. Vitamin Ks, γ-oryzanol, dibenzoylthiamine, dibenzoylthiamine hydrochloride; Vitamin B1s such as thiamine and salts thereof (eg, dibenzoylthiamine hydrochloride, thiamine hydrochloride, thiamine diphosphate); hydrochloric acid Vitamin B6s such as pyridoxine, pyridoxine acetate, pyridoxal hydrochloride, pyridoxal hydrochloride, pyridoxamine hydrochloride, pyridoxamine hydrochloride; vitamin B12s such as cyanocobalamin, hydroxocobalamin, deoxyadenosylcobalamin; folic acids such as folic acid and pteroylglutamic acid; retinol, Retinol derivatives such as retinol acetate, retinol palmitate, retinol propionate and retinol linoleate, vitamins A such as retinal, retinoic acid and tocopheryl retinoate; Vitamin A; Pantothenic Acid, Calcium Pantothenate, Pantothenyl Alcohol (Panthenol), Pantothenic Acids such as D-Panthesin, D-Pantethine, Coenzyme A, Pantothenyl Ethyl Ether; Biotins such as Biotin, Bioticin; Carnitine , Ferulic acid, α-lipoic acid, orotic acid, γ-oryzanol, pyrroloquinoline quinone, glucosyl hesperidin, and ubiquinone.
<有機酸>
有機酸としては、例えば、グルコン酸、アスパラギン酸、アミノエチルスルホン酸、クエン酸、グルタミン酸、コハク酸、シュウ酸、フマル酸、マロン酸、マレイン酸、プロピオン酸、リンゴ酸、サリチル酸、グリコール酸、フィチン酸、酒石酸、酢酸、乳酸、パントテン酸、アルギン酸、アスコルビン酸、安息香酸、アジピン酸、グルタミン酸、アゼライン酸及びこれらの塩が挙げられる。塩としては、例えば、硫酸、塩酸又はリン酸などの鉱酸の塩、マレイン酸又はメタンスルホン酸などの有機酸の塩、ナトリウム又はカリウムなどのアルカリ金属塩、アルカリ土類金属塩、アンモニウム塩、塩基性アミノ酸塩、トリエタノールアミンのようなアミン塩などが挙げられる。なかでもグルコン酸、クエン酸、グルタミン酸、コハク酸、リンゴ酸、サリチル酸、グリコール酸、フィチン酸、酒石酸、乳酸、及びこれらの塩から選ばれる1種又は2種以上との組み合わせが好ましく、グルコン酸、クエン酸、グルタミン酸、コハク酸、サリチル酸、グリコール酸、フィチン酸、酒石酸、乳酸及びこれらの塩から選ばれる1種又は2種以上との組み合わせがより好ましい。
<Organic acid>
Examples of the organic acid include gluconic acid, aspartic acid, aminoethylsulfonic acid, citric acid, glutamic acid, succinic acid, oxalic acid, fumaric acid, malonic acid, maleic acid, propionic acid, malic acid, salicylic acid, glycolic acid, phytin. Examples thereof include acids, tartaric acid, acetic acid, lactic acid, pantothenic acid, alginic acid, ascorbic acid, benzoic acid, adipic acid, glutamic acid, azelaic acid and salts thereof. Examples of the salt include salts of mineral acids such as sulfuric acid, hydrochloric acid or phosphoric acid, salts of organic acids such as maleic acid or methanesulfonic acid, alkali metal salts such as sodium or potassium, alkaline earth metal salts, ammonium salts, Examples thereof include basic amino acid salts and amine salts such as triethanolamine. Among them, gluconic acid, citric acid, glutamic acid, succinic acid, malic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid, lactic acid, and a combination thereof with one or more selected from salts thereof are preferable, and gluconic acid, A combination with one or more selected from citric acid, glutamic acid, succinic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid, lactic acid and salts thereof is more preferable.
<ペプチド又はその誘導体>
ペプチド又はその誘導体としては、例えば、ケラチン分解ペプチド、加水分解ケラチン、コラーゲン、魚由来コラーゲン、アテロコラーゲン、サクシニル化アテロコラーゲン、ゼラチン、エラスチン、エラスチン分解ペプチド、コラーゲン分解ペプチド、加水分解コラーゲン、塩化ヒドロキシプロピルアンモニウム加水分解コラーゲン、エラスチン分解ペプチド、コンキオリン分解ペプチド、加水分解コンキオリン、シルク蛋白分解ペプチド、加水分解シルク、ラウロイル加水分解シルクナトリウム、大豆蛋白分解ペプチド、加水分解大豆蛋白、小麦蛋白、小麦蛋白分解ペプチド、加水分解小麦蛋白、カゼイン分解ペプチド、アシル化ペプチド(パルミトイルオリゴペプチド、パルミトイルペンタペプチド、パルミトイルテトラペプチドなど)などが挙げられる。
<Peptide or derivative thereof>
Examples of the peptide or its derivative include keratin-degrading peptide, hydrolyzed keratin, collagen, fish-derived collagen, atelocollagen, succinylated atelocollagen, gelatin, elastin, elastin-degrading peptide, collagen-degrading peptide, hydrolyzed collagen, hydroxypropylammonium chloride. Degraded collagen, elastin degrading peptide, conchiolin degrading peptide, hydrolyzing conchiolin, silk protein degrading peptide, hydrolyzed silk, lauroyl hydrolyzed silk sodium, soybean protein degrading peptide, hydrolyzed soybean protein, wheat protein, wheat protein degrading peptide, hydrolysis Examples include wheat proteins, casein-degrading peptides, acylated peptides (palmitoyl oligopeptides, palmitoyl pentapeptides, palmitoyl tetrapeptides, etc.) and the like.
<アミノ酸又はその誘導体>
アミノ酸又はその誘導体としては、例えば、ベタイン(トリメチルグリシン)、プロリン、ヒドロキシプロリン、アルギニン、リジン、セリン、グリシン、アラニン、フェニルアラニン、β−アラニン、スレオニン、グルタミン酸、グルタミン、アスパラギン、アスパラギン酸、システイン、シスチン、メチオニン、ロイシン、イソロイシン、バリン、ヒスチジン、タウリン、γ−アミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸、カルニチン、カルノシン、クレアチン、N−ステアロイル−L−グルタミン酸ナトリウムなどが挙げられる。
<Amino acid or its derivative>
Examples of the amino acid or its derivative include betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, alanine, phenylalanine, β-alanine, threonine, glutamic acid, glutamine, asparagine, aspartic acid, cysteine, cystine. , Methionine, leucine, isoleucine, valine, histidine, taurine, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid, carnitine, carnosine, creatine, sodium N-stearoyl-L-glutamate and the like.
<洗浄成分>
洗浄成分としては、ラウリン酸カリウム、ミリスチン酸カリウム、パルミチン酸カリウム又はステアリン酸カリウムなどのアルカリ金属塩、アルカノールアミド塩又はアミノ酸塩などの石けん類、ココイルグルタミン酸ナトリウム、ココイルメチルタウリンナトリウムなどのアミノ酸系界面活性剤、ラウレス硫酸ナトリウムなどのエーテル硫酸エステル塩、ラウリルエーテル酢酸ナトリウムなどのエーテルカルボン酸塩、アルキススルホコハク酸エステルナトリウムなどのスルホコハク酸エステル塩、ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸ジエタノールアミドなどの脂肪酸アルカノールアミド、ラウリルリン酸ナトリウム、ポリオキシエチレンラウリルエーテルリン酸ナトリウムなどのモノアルキルリン酸エステル塩、ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ラウリルジメチルアミノ酢酸ベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルヒドロキシスルホベタイン及びラウロイルアミドエチルヒドロキシエチルカルボキシメチルベタインヒドロキシプロピルリン酸ナトリウムなどのベタイン型両性界面活性剤、ラウリルアミノプロピオン酸ナトリウムなどのアミノ酸型両性界面活性剤などが挙げられる。
<Cleaning ingredients>
As the cleaning component, an alkali metal salt such as potassium laurate, potassium myristate, potassium palmitate or potassium stearate, a soap such as an alkanolamide salt or an amino acid salt, and an amino acid-based interface such as sodium cocoyl glutamate and sodium cocoyl methyl taurate. Activator, ether sulfate ester salt such as sodium laureth sulfate, ether carboxylate salt such as sodium lauryl ether acetate, sulfosuccinate ester salt such as sodium alkyssulfosuccinate, coconut oil fatty acid monoethanolamide, coconut oil fatty acid diethanolamide, etc. Fatty acid alkanolamides, sodium lauryl phosphate, monoalkyl phosphate ester salts such as sodium polyoxyethylene lauryl ether phosphate, coconut oil fatty acid amide propyldimethylaminoacetic acid betaine, lauryldimethylaminoacetic acid betaine, 2-alkyl-N-carboxyl Betaine-type amphoteric surfactants such as methyl-N-hydroxyethylimidazolinium betaine, lauryl hydroxysulfobetaine and lauroylamidoethyl hydroxyethyl carboxymethyl betaine hydroxypropyl sodium phosphate, amino acid-type amphoteric surfactants such as sodium laurylaminopropionate Agents and the like.
<角質柔軟成分>
角質柔軟成分としては、例えば、ラノリン、尿素、フィチン酸、乳酸、乳酸塩、グリコール酸、サリチル酸、リンゴ酸、クエン酸、フルーツ酸、フィチン酸、尿素、イオウなどが挙げられる。なかでも、乳酸、乳酸ナトリウム、グリコール酸、サリチル酸、フィチン酸、クエン酸が好ましい。
<Keratin soft ingredient>
Examples of the keratin softening component include lanolin, urea, phytic acid, lactic acid, lactate, glycolic acid, salicylic acid, malic acid, citric acid, fruit acid, phytic acid, urea and sulfur. Of these, lactic acid, sodium lactate, glycolic acid, salicylic acid, phytic acid, and citric acid are preferable.
<細胞賦活化成分>
細胞賦活化成分としては、例えば、γ−アミノ酪酸、ε−アミノカプロン酸などのアミノ酸類:レチノール、チアミン、リボフラビン、塩酸ピリドキシン、パントテン酸ピロロキノリンキノン類などのビタミン類;グルコン酸、フィチン酸、グリコール酸、乳酸などのα−ヒドロキシ酸類;タンニン、柿タンニン、フラボノイド、サポニン、アラントイン、感光素301号、パンテノール、植物(たとえば、ダイズ芽、ビルベリー葉など)に由来する成分などが挙げられる。
<Cell activation component>
Examples of the cell activating component include amino acids such as γ-aminobutyric acid and ε-aminocaproic acid: vitamins such as retinol, thiamine, riboflavin, pyridoxine hydrochloride, and pyrroloquinoline quinone pantothenate; gluconic acid, phytic acid, glycol Α-hydroxy acids such as acid and lactic acid; tannin, persimmon tannin, flavonoid, saponin, allantoin, Photosensitizer No. 301, panthenol, components derived from plants (eg, soybean sprouts, bilberry leaves, etc.) and the like.
<老化防止成分>
老化防止成分としては、例えば、加水分解大豆蛋白、レチノイド(レチノール、レチノイン酸、レチナールなど)、パンガミン酸、ウルソール酸、ウコンエキス、スフィンゴシン誘導体、ケイ素、ケイ酸、N−メチル−L−セリン、メバロノラクトン、ペプチド類(カプロオイルテトラペプチド−3、オリゴペプチド−24など)などが挙げられる。なかでも、加水分解大豆蛋白、レチノール、酢酸レチノール、パルミチン酸レチノール、カプロオイルテトラペプチド−3、オリゴペプチド−24が好ましい。
<Anti-aging ingredient>
Examples of the antiaging component include hydrolyzed soybean protein, retinoid (retinol, retinoic acid, retinal, etc.), pangamic acid, ursolic acid, turmeric extract, sphingosine derivative, silicon, silicic acid, N-methyl-L-serine, mevalonolactone. , Peptides (caproyl tetrapeptide-3, oligopeptide-24, etc.) and the like. Of these, hydrolyzed soybean protein, retinol, retinol acetate, retinol palmitate, caproyl tetrapeptide-3 and oligopeptide-24 are preferable.
<抗糖化成分>
抗糖化成分としては、例えば、ブドレジャアキシラリス葉エキス、ウメ果実エキス、エーデルワイスエキスなどの植物エキス、月見草油、アムラーの果実、果汁又はそれらの抽出物、L−アルギニン、L−リジン、加水分解カゼイン、加水分解性タンニン、カルノシンなどが挙げられる。
<Anti-glycation component>
Examples of the anti-saccharification component include plant extracts such as Budreja axillaris leaf extract, plum fruit extract, and edelweiss extract, evening primrose oil, Amla fruit, fruit juice or their extracts, L-arginine, L-lysine, and hydrolysis. Examples include casein, hydrolyzable tannin, carnosine and the like.
<頭皮毛髪ケア成分>
頭皮毛髪ケア成分としては、例えば、ミノキシジル、フィナステリド、カルプロニウム塩化物、ピリジンN−オキシド、ニコチン酸誘導体(ニコチン酸アミド、ニコチン酸ベンジル、ニコチン酸トコフェロールなど)、γ−オリザノール、トウガラシチンキ、セファランチン、ビタミンB2類、ビタミンB6類、ビタミンB12類、パントテン酸、酢酸トコフェロール、トコフェロール、パンテノール、ビオチン、加水分解ダイズタンパク、ダイズ抽出物、ヨクイニン、イチョウエキス、ニンジン抽出物、センブリエキス、アロエ抽出物、当帰抽出物、ウスベニアオイ抽出物、カフェイン、カミツレ抽出物、海藻エキス、フコイダン、ゲンチアナ抽出物、エンメイソウ抽出物、チクセツニンジンチンキ、カシュウチンキ、アルニカチンキ、女性ホルモン(エストラジオールなど)などが挙げられる。
<Scalp hair care ingredients>
Examples of the scalp hair care component include minoxidil, finasteride, carpronium chloride, pyridine N-oxide, nicotinic acid derivative (nicotinamide, benzyl nicotinate, tocopherol nicotinate, etc.), γ-oryzanol, capsicum tincture, cepharanthin, vitamin. B2s, Vitamin B6s, Vitamin B12s, Pantothenic acid, Tocopherol acetate, Tocopherol, Panthenol, Biotin, Hydrolyzed soy protein, Soybean extract, Yokuinin, Ginkgo biloba extract, Carrot extract, Assemblage extract, Aloe extract, etc. The natural extract, the mallow extract, the caffeine, the chamomile extract, the seaweed extract, the fucoidan, the gentian extract, the neem extract, the citrus ginseng tincture, the cashew tincture, the arnica tincture, the female hormones (such as estradiol) and the like can be mentioned.
<pH>
本発明の頭皮用制汗組成物のpHは、本発明の効果を奏し得る限り特に限定はされないが、例えば、pH3以上であり、好ましくはpH3.5以上であり、より好ましくはpH4以上であり、pH9以下、好ましくはpH8以下、さらに好ましくはpH7.5以下である。
<pH>
The pH of the scalp antiperspirant composition of the present invention is not particularly limited as long as the effects of the present invention can be exhibited, but is, for example, pH 3 or more, preferably pH 3.5 or more, and more preferably pH 4 or more. , PH 9 or less, preferably pH 8 or less, and more preferably pH 7.5 or less.
<剤型>
本発明の頭皮用制汗組成物は、公知の形態であれば特に限定されないが、例えば、液剤、懸濁化剤、乳剤、クリーム剤、軟膏剤、ゲル剤、リニメント剤、ローション剤、エアゾール剤、パウダー剤、不織布などのシートに頭皮用制汗組成物を含浸させたシート剤、ミスト剤などの形態により、公知の方法で製剤化することができる。なかでも、液剤、懸濁化剤、乳剤、クリーム剤、乳液、軟膏剤、ゲル剤、ローション剤、シート剤、エアゾール剤、ミスト剤が好適であり、液剤、懸濁化剤、乳液、ゲル剤、ローション剤、シート剤、エアゾール剤、ミスト剤がさらに好適であり、液剤、懸濁化剤、ローション剤、シート剤、エアゾール剤、ミスト剤がさらにより好適である。
<Formulation>
The antiperspirant composition for scalp of the present invention is not particularly limited as long as it is a known form, and for example, a liquid agent, a suspending agent, an emulsion, a cream agent, an ointment agent, a gel agent, a liniment agent, a lotion agent, an aerosol agent. It can be formulated by a known method depending on the form of a sheet agent, a mist agent or the like obtained by impregnating a sheet such as a powder agent or a non-woven fabric with the antiperspirant composition for scalp. Of these, liquids, suspending agents, emulsions, creams, emulsions, ointments, gels, lotions, sheets, aerosols and mists are preferable, and liquids, suspending agents, emulsions, gels. , Lotion agents, sheet agents, aerosol agents and mist agents are more preferable, and liquid agents, suspending agents, lotion agents, sheet agents, aerosol agents and mist agents are even more preferable.
<エアゾール剤>
エアゾール剤は、上記頭皮用制汗組成物と噴射剤とをエアゾール型スプレー容器に充填されるものである。エアゾール剤に用いられる噴射剤としては、例えば、フロン11、フロン12、フロン21、フロン113、フロン114、フロン134aなどのフロンガス、プロパン、イソブタン、ノルマルブタンなどの液化石油ガス(LPG)、及ジメチエルエーテル(DME)などの液化ガスなどが挙げられる。また、これらに加えて炭酸ガス、窒素ガス、酸素ガスなどを用いてもよい。
<Aerosol agent>
The aerosol is prepared by filling the scalp antiperspirant composition and the propellant in an aerosol-type spray container. Examples of the propellant used for the aerosol agent include CFCs such as CFC 11, CFC 12, CFC 21, CFC 113, CFC 114, CFC 134a, liquefied petroleum gas (LPG) such as propane, isobutane, and normal butane, and dimethicone. Liquefied gas such as Lether (DME) may be used. In addition to these, carbon dioxide gas, nitrogen gas, oxygen gas and the like may be used.
頭皮用制汗組成物と噴射剤との比率(頭皮用制汗組成物/噴射剤の重量比)は特に制限されないが、通常、1:9〜9:1であり、2:8〜8:2が好ましい。 The ratio of the scalp antiperspirant composition to the propellant (weight ratio of scalp antiperspirant composition/propellant) is not particularly limited, but is usually 1:9 to 9:1 and 2:8 to 8:. 2 is preferred.
<シート剤>
シート剤は、本発明の頭皮用制汗組成物をシート基材に含浸させてなるものである。シート基材としては、頭皮用制汗組成物を含浸担持することが可能であれば特に限定されず、織布、不織布などを任意に使用することができる。上記織布、不織布を構成する繊維としては、特に限定されず、例えば、合成繊維、天然繊維、又はこれらを混合組み合わせてなる繊維などから選択できる。具体的には、レーヨン線維、コットン、パルプ、セルロース、テンセル、リヨセル、キチン、キトサン、コラーゲン、アルギン酸などの線維素材を挙げることができるが、これらに限定されない。また、任意の熱可塑性バインダーを含むことができ、例えば、ポリエチレンやポリプロピレンなどのポリオレフィン系;ポリエチレンテレフタレート、ポリトリメチレンテレフタレート、ポリブチレンテレフタレート、ポリエチレンナフタレート、ポリブチレンナフタレートなどのポリエステル系;ナイロンなどのポリアミド系;ポリアクリロニトリル系などの各種樹脂から構成される熱可塑性バインダーを挙げることができるが、これらに限定されない。また、不織布に含まれる熱可塑性バインダーは、上記のなかから1種を単独で含んでいてもよく、2種以上を任意に組み合わせて含んでいてもよい。
また、シート基材の目付けは、特に限定されず、例えば、10〜100g/m2、好ましくは20〜80g/m2、より好ましくは30〜70g/m2、更に好ましくは30〜60g/m2である。
また、シート基材は、任意の形状が規則的又は不規則的に表面及び裏面の少なくとも一方面に凹凸形状で表される立体模様を有するシート基材であっても、かかる立体模様を有さないシート基材であってもよい。上記凹凸形状は、例えば、メッシュ加工、エンボス加工、ドット加工又はこれらの加工法の組み合わせなどの任意の方法により加工することができ、メッシュ加工を含む方法(例えば、メッシュ加工のみを施す方法、メッシュ加工とエンボス加工とを組み合わせた方法、メッシュ加工とドット加工を組み合わせた方法など)が好ましい。
また、シート基材に含浸させる頭皮用制汗組成物の量は、特に限定されず、通常シート基材の重量の0.5倍〜20倍の範囲で含浸させることができ、好ましくは1倍〜10倍である。
本発明の頭皮用制汗組成物を含浸した頭皮用シート剤は、当該頭皮用シート剤を用いて頭部を拭くことにより、頭皮からの汗の発生を抑制すると共に、頭皮の皮膚常在菌に対する影響を抑えつつ、頭皮の臭いを抑制できることにくわえて、汗や皮脂などを拭き取ることができ、簡便にリフレッシュできる点で好ましい。なかでも、本発明の頭皮用制汗組成物を含浸した頭皮用シート剤は、例えば、汗をかきやすい前額部周辺や臭いのこもりやすい後頭部周辺を拭く場合、丸刈りや短髪などショートヘアの頭部全体を拭く場合などにより一層好適に用いられる。
<Sheet agent>
The sheet agent is obtained by impregnating a sheet base material with the antiperspirant composition for scalp of the present invention. The sheet base material is not particularly limited as long as it can impregnate and carry the scalp antiperspirant composition, and woven fabric, non-woven fabric, and the like can be arbitrarily used. The fibers constituting the woven or non-woven fabric are not particularly limited, and can be selected from, for example, synthetic fibers, natural fibers, or fibers obtained by mixing and combining these. Specific examples thereof include fiber materials such as rayon fiber, cotton, pulp, cellulose, tencel, lyocell, chitin, chitosan, collagen, and alginic acid, but are not limited thereto. Further, it may contain any thermoplastic binder, for example, polyolefin type such as polyethylene and polypropylene; polyester type such as polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate and polybutylene naphthalate; nylon and the like. Polyamide-based; polyacrylonitrile-based thermoplastic binders composed of various resins, but are not limited thereto. Further, the thermoplastic binder contained in the nonwoven fabric may contain one kind alone from the above, or may contain two or more kinds in arbitrary combination.
The basis weight of the sheet base material is not particularly limited, and is, for example, 10 to 100 g/m 2 , preferably 20 to 80 g/m 2 , more preferably 30 to 70 g/m 2 , and further preferably 30 to 60 g/m 2 . Is 2 .
Further, the sheet base material does not have such a three-dimensional pattern, even if the sheet base material has a three-dimensional pattern in which at least one surface of the front surface and the back surface is irregularly and regularly expressed in any shape. It may be a non-sheet base material. The concavo-convex shape can be processed by any method such as mesh processing, embossing, dot processing, or a combination of these processing methods. A method including mesh processing (for example, a method of performing only mesh processing, a mesh A method combining processing and embossing, a method combining mesh processing and dot processing, etc.) are preferable.
The amount of the scalp antiperspirant composition with which the sheet base material is impregnated is not particularly limited, and it can be usually impregnated in the range of 0.5 to 20 times the weight of the sheet base material, preferably 1 time. 10 times.
The scalp sheet agent impregnated with the anti-perspirant composition for scalp of the present invention is, by wiping the head with the scalp sheet agent, suppresses the generation of sweat from the scalp, and skin resident bacteria of the scalp. In addition to being able to suppress the odor of the scalp while suppressing the effect on the above, it is preferable in that the sweat and the sebum can be wiped off and the refreshment can be easily performed. Among them, the scalp sheet agent impregnated with the anti-perspirant composition for scalp of the present invention is, for example, when wiping around the forehead part where sweat is easily wiped or around the occipital region where odor is likely to be muffled, the head of short hair such as cut hair or short hair. It is more preferably used when the entire part is wiped.
<容器>
本発明の頭皮用制汗組成物は、使用目的及び用途に応じ、適宜選択した形状、材質の容器に収容し、使用することができる。具体的な容器としては、例えば、スプレータイプ、ボトルタイプ、チューブタイプ、ジャータイプ、スポイドタイプ、ディスペンサータイプ、スティックタイプ、パウチ袋、及びチアパックなどを例示できる。本発明の頭皮用制汗組成物は、頭皮への塗布のしやすさの観点で、各容器のヘッド部をスポンジ状ヘッド、滴下型ヘッド、ペン型ヘッド、ロールオン型ヘッド、ヘラ状ヘッド、ブラシ状ヘッド、剣山型ヘッドなどに変更して用いることができる。また、容器の材質としては、ポリエチレンテレフタレート、ポリプロピレン、ポリエチレン(HDPE、LDPE、LLDPEなど)、ABS樹脂、エチレンビニルアルコール樹脂、ポリスチレン、ガラス、及び金属(アルミなど)などを例示できる。また、これらの材料は、強度、柔軟性、耐候性、又は成分の安定性などを考慮し、各種コーティング処理を行ったり、これらの材料を例えば混合するなどして組み合わせたり、積層したりして、容器材料として用いることができる。コーティングの材質としては、エポキシ樹脂、ポリアミドイミドなどを例示できる。なかでも、ポリエチレンテレフタレート、ポリプロピレン、ポリエチレン(HDPE、LDPE、LLDPEなど)、エチレンビニルアルコール樹脂、金属(アルミなど)を用いることが好ましい。
<Container>
The antiperspirant composition for scalp of the present invention can be used by containing it in a container having a shape and a material appropriately selected according to the purpose of use and application. Specific examples of the container include spray type, bottle type, tube type, jar type, spoid type, dispenser type, stick type, pouch bags, and cheer packs. The anti-perspirant composition for scalp of the present invention has a sponge head, a drip-type head, a pen-type head, a roll-on type head, a spatula-shaped head, and a brush for the head portion of each container from the viewpoint of easy application to the scalp. It can be used by changing it to a circular head or a sword-shaped head. Examples of the material of the container include polyethylene terephthalate, polypropylene, polyethylene (HDPE, LDPE, LLDPE, etc.), ABS resin, ethylene vinyl alcohol resin, polystyrene, glass, metal (aluminum, etc.), and the like. Further, these materials may be subjected to various coating treatments in consideration of strength, flexibility, weather resistance, stability of components, etc., or these materials may be combined, for example, by mixing, or laminated. Can be used as a container material. Examples of the coating material include epoxy resin and polyamide-imide. Among them, polyethylene terephthalate, polypropylene, polyethylene (HDPE, LDPE, LLDPE, etc.), ethylene vinyl alcohol resin, and metal (aluminum, etc.) are preferably used.
シート剤の容器としては、密閉性の高い容器で包装して提供されることが好ましい。シート剤は、一回使い切りのタイプとして個包装されてもよいし、又は複数回にわたり使用できるように、使用回数分の拭き取りシート剤を纏めて包装してもよい。複数回使用タイプとして包装する場合には、使用の度に蓋を開閉できるようにして、使用しないときには開口部を閉じた状態にできるような構造を備えた容器であることが好ましい。ここで、開口部を開閉可能な状態にする蓋部材は、容器と一体成形された蓋部材であってもよいし、容器に連結された蓋部材であってもよいし、又は容器から取り外し可能な状態の蓋部材であってもよい。容器から取り外し可能な状態の蓋部材としては、例えば、粘着層を備えたシール状の部材であって、使用の度に開口部を粘着層でシールできるものなどであってもよい。また、シール状部材を用いる場合、粘着層は必ずしも蓋部材側の表面に存在する必要はなく、容器側の表面(例えば、開口部の周囲など)に存在してもよい。容器及び蓋部材の材質としては、当該分野で周知の任意の気密性に優れた材質のものを用いることができ、例えば、ポリエチレンやポリプロピレンなどのポリオレフィン系樹脂;アルミニウムなどの金属;アルミ箔をラミネートしたラミネートフィルムなどを挙げることができるが、これらに限定されない。外出時などに持ち運びし易く、取扱いが容易であるという観点から、好ましくはアルミ箔をラミネートしたラミネートフィルムで構成される袋状の容器であって、シール状の蓋部材で開口部を使用の度に開閉可能な状態にした容器で包装されることが好ましい。 As the container for the sheet material, it is preferable to provide the container by packaging it in a highly hermetic container. The sheet material may be individually packaged as a one-time use type, or may be packaged together with the wiping sheet material for the number of times of use so that it can be used multiple times. In the case of packaging as a multi-use type, it is preferable that the container has a structure in which the lid can be opened and closed each time it is used and the opening can be closed when not in use. Here, the lid member that opens and closes the opening may be a lid member integrally formed with the container, a lid member connected to the container, or removable from the container. The lid member may be in any state. The lid member that can be detached from the container may be, for example, a seal-like member provided with an adhesive layer, the opening of which can be sealed with the adhesive layer each time it is used. Further, when the seal-like member is used, the adhesive layer does not necessarily have to be present on the surface of the lid member side, and may be present on the surface of the container side (for example, around the opening). As the material of the container and the lid member, any material well known in the art and having excellent airtightness can be used. For example, a polyolefin resin such as polyethylene or polypropylene; a metal such as aluminum; a laminate of aluminum foil. Examples of the laminated film include, but are not limited to: From the viewpoint of being easy to carry and handle when going out, it is preferably a bag-shaped container composed of a laminated film laminated with aluminum foil, and the opening is provided by a seal-shaped lid member. It is preferably packaged in a container that can be opened and closed.
<使用用途>
医薬部外品又は化粧品用の組成物とする場合の用途としては具体的には、例えば、化粧水、乳液、ジェル、クリーム、美容液、日焼け止め機能付き化粧料、ミスト、スプレー、拭き取りシートのような頭皮用の基礎化粧料;並びにドライシャンプー、シャンプー、リンス、及びトリートメントのような洗浄用化粧料などが挙げられる。
<Use>
Specific examples of the use as a composition for quasi-drugs or cosmetics include, for example, lotion, emulsion, gel, cream, beauty essence, cosmetics with sunscreen function, mist, spray, and wipe sheet. Such as basic cosmetics for the scalp; and cleansing cosmetics such as dry shampoos, shampoos, rinses and treatments.
<粘度>
本発明の頭皮用制汗組成物の粘度(25℃)は、本発明の効果を奏し得る限り特に限定はされないが、例えば、液剤、懸濁化剤、ローション剤、エアゾール剤、ミスト剤、シート剤の場合、0.01〜50000mPa・sの範囲が好ましい。さらに、0.1〜5000mPa・sの範囲がさらに好ましく、1〜1000mPa・sの範囲がより好ましい。乳液、ジェル、クリームの場合は10〜1000000mPa・sの範囲が好ましい。さらに、1000〜500000mPa・sの範囲がさらに好ましく、10000〜100000mPa・sの範囲がより好ましい。なお、前記粘度(25℃:mPa・s)は、第17改正日本薬局方の一般試験法に記載の粘度測定法に準拠し、単一円筒形回転粘度計(ブルックフィールド型粘度計)にて測定した粘度である。
<Viscosity>
The viscosity (25° C.) of the scalp antiperspirant composition of the present invention is not particularly limited as long as the effects of the present invention can be exhibited, but for example, a liquid agent, a suspending agent, a lotion agent, an aerosol agent, a mist agent, and a sheet. In the case of the agent, the range of 0.01 to 50,000 mPa·s is preferable. Furthermore, the range of 0.1-5000 mPa*s is more preferable, and the range of 1-1000 mPa*s is more preferable. In the case of emulsion, gel, and cream, the range of 10 to 1,000,000 mPa·s is preferable. Furthermore, the range of 1000-500000 mPa*s is further preferable, and the range of 10000-100000 mPa*s is more preferable. The viscosity (25° C.: mPa·s) was measured by a single cylindrical rotary viscometer (Brookfield viscometer) according to the viscosity measurement method described in the general test method of the 17th revised Japanese Pharmacopoeia. It is the measured viscosity.
<製法>
本発明の頭皮用制汗組成物の製法としては、特に制限はなく、剤型及び形態に応じた常法により、(A)〜(D)成分及びその他の成分を溶解、混合あるいは分散などすることにより製造できる。
<Production method>
The method for producing the antiperspirant composition for scalp of the present invention is not particularly limited, and the components (A) to (D) and other components are dissolved, mixed or dispersed by a conventional method depending on the dosage form and form. It can be manufactured.
<用途>
本発明は、頭皮に有用な頭皮用制汗組成物であり、頭皮の皮膚常在菌コントロール用、又は頭皮の臭い抑制用として用いることができる。頭皮の皮膚常在菌コントロール用として用いる剤は、頭皮の皮膚常在菌であるスタフィロコッカス カプティス(Staphylococcus captis)に対する殺菌効果を抑えることにより、頭皮の皮膚常在菌のバランスの崩れを抑制できる点で有益である。具体的には、特定の殺菌成分と制汗成分とを併用する頭皮の皮膚常在菌コントロール剤は、当該殺菌成分又は制汗成分のうちスタフィロコッカス カプティスに対する殺菌効果が相対的に高い成分における当該殺菌効果を上回る殺菌効果を生じさせないため、頭皮の皮膚常在菌に対する殺菌効果を抑えることができ、頭皮の皮膚常在菌のバランスの崩れを抑制できる点で有益である。なお、殺菌効果は、後述の拡散法(穿孔平板法)による試験によって確認することができる。また、特定の殺菌成分と制汗成分とを併用し、頭皮の臭い抑制用として用いる剤は、頭皮の皮膚常在菌であるスタフィロコッカス カプティスによる代謝を抑えることにより、頭皮の臭いを抑制できる点で有益である。また、特定の殺菌成分と制汗成分とを併用し、頭皮の臭い抑制用として用いる剤は、臭いを長時間抑制でき、抑制効果に持続性があるため、臭いを気にせずに過ごせる点で特に有益である。
<Use>
INDUSTRIAL APPLICABILITY The present invention is a scalp antiperspirant composition useful for the scalp, and can be used for controlling skin-resident bacteria of the scalp or for suppressing odor of the scalp. The agent used for controlling the skin-resident bacteria of the scalp can suppress the imbalance of the skin-resident bacteria of the scalp by suppressing the bactericidal effect on Staphylococcus captis, which is the skin-resident bacteria of the scalp. It is beneficial in terms. Specifically, a scalp skin indigenous bacteria control agent that uses a combination of a specific bactericidal component and an antiperspirant component is a component having a relatively high bactericidal effect against Staphylococcus captis among the bactericidal component or the antiperspirant component. Since the bactericidal effect exceeding the bactericidal effect is not produced, the bactericidal effect of the scalp on the skin indigenous bacteria can be suppressed, which is advantageous in that the balance of the skin resident bacteria on the scalp can be suppressed. The bactericidal effect can be confirmed by a test by a diffusion method (perforated flat plate method) described later. In addition, a combination of a specific bactericidal component and an antiperspirant component, which is used to suppress the odor of the scalp, can suppress the odor of the scalp by suppressing the metabolism of Staphylococcus captis, which is a skin-resident bacterium of the scalp. It is beneficial in terms. In addition, a combination of a specific bactericidal component and an antiperspirant component, which is used to suppress the odor of the scalp, can suppress the odor for a long time, and since the suppression effect is persistent, it is possible to spend without worrying about the odor. Especially useful.
また、頭皮の皮膚常在菌のバランスが崩れると、頭皮の健康状態が悪化し、毛髪の脱毛などが助長され、毛髪の正常な成長が阻害される恐れがあるところ、本発明は、頭皮の皮膚常在菌であるスタフィロコッカス カプティス(Staphylococcus captis)に対する殺菌効果を抑えることにより、頭皮の皮膚常在菌のバランスの崩れを抑制できるので、頭皮に適用する育毛用、養毛用、発毛用、毛生促進用、脱毛予防用、薄毛改善用、細毛改善用、軟毛改善用、フケ症予防又は改善用の毛髪用化粧料に本発明の頭皮用制汗組成物を含んでもよい。 Further, when the balance of skin-resident bacteria of the scalp is disturbed, the health condition of the scalp is deteriorated, hair loss and the like are promoted, and normal growth of hair may be inhibited. By suppressing the bactericidal effect against Staphylococcus captis, which is a skin-resident bacterium, it is possible to prevent the balance of the skin-resident bacteria on the scalp from being disrupted. The scalp antiperspirant composition of the present invention may be contained in a hair cosmetic composition for use in hair care, promotion of hair growth, prevention of hair loss, improvement of thin hair, improvement of thin hair, improvement of soft hair, prevention or improvement of dandruff.
また、頭皮で汗をかくと、髪の毛や帽子によって蒸れが生じるため、上記皮膚常在菌のバランスへの影響や臭いの発生に加えて、かゆみや不快感が生じやすくなる。本発明は、頭皮に有用な頭皮用制汗組成物であるため、例えば、気温や湿度が高い時期の使用に加えて、帽子を着用する時(特に長時間着用時)、朝の整髪前、人と接近する場面、運動の前後、気分転換したい時などの使用場面において好適に用いられる。 Further, when the scalp sweats, stuffiness occurs due to the hair or the hat, so that it is easy to cause itching and discomfort in addition to the above-mentioned effects on the balance of skin-resident bacteria and the generation of odor. INDUSTRIAL APPLICABILITY The present invention is a scalp antiperspirant composition useful for the scalp, and therefore, for example, in addition to use during periods when the temperature and humidity are high, when wearing a hat (especially when wearing for a long time), before styling in the morning, It is suitable for use in situations where people approach people, before and after exercise, when they want to change their mood, and so on.
<方法>
本発明は、フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、制汗成分とを用いる、頭皮の皮膚常在菌をコントロールする方法を含むものである。また、本発明は、フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、制汗成分とを用いる、頭皮の臭いを抑制する方法を含むものである。また、本発明は、フェノール系殺菌成分、第四級アンモニウム塩、ピロクトンオラミン、グリチルレチン酸、及びジンクピリチオンからなる群より選択される少なくとも1種と、制汗成分とを用いる、頭皮用制汗組成物の垂れ落ちを抑制する方法をも含むものである。
<Method>
The present invention uses at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione, and an antiperspirant component, and skin-resident bacteria of the scalp. It includes a method of controlling the. Further, the present invention uses at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione, and an antiperspirant component to reduce the odor of the scalp. The method of suppressing is included. Further, the present invention uses at least one selected from the group consisting of a phenolic bactericidal component, a quaternary ammonium salt, piroctone olamine, glycyrrhetinic acid, and zinc pyrithione, and an antiperspirant component for the scalp. It also includes a method of suppressing the composition from dripping.
以下に本発明を実施例に基づいてさらに詳細に説明するが、本発明はこれら実施例に限定されるものではない。 Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited to these examples.
[試験例1.殺菌効果評価試験]
頭皮の皮膚常在菌に対する本発明の殺菌効果を評価するために、頭皮の皮膚常在菌としてスタフィロコッカス カプティス(Staphylococcus captis)、殺菌成分としてイソプロピルメチルフェノール、塩化ベンザルコニウム及びヒノキチオール、制汗成分としてクロルヒドロキシアルミニウム及びパラフェノールスルホン酸亜鉛を用意し、以下の拡散法(穿孔平板法)による試験を行った。
[Test Example 1. Sterilization effect evaluation test]
In order to evaluate the bactericidal effect of the present invention on the skin resident bacteria of the scalp, Staphylococcus captis (Staphylococcus captis) as the skin resident bacteria of the scalp, isopropylmethylphenol, benzalkonium chloride and hinokitiol as bactericidal components, and antiperspirant Chlorhydroxyaluminum and zinc paraphenolsulfonate were prepared as components, and a test was conducted by the following diffusion method (perforated plate method).
スタフィロコッカス カプティスの菌液を約106CFU/mL接種したMH寒天培地(Mueller−Hinton寒天培地、シャーレ 直径9cm)に拡散し、滅菌済みの穿孔カッター(TOYOBO社製、バイオプシーパンチ8mm、ステンレス製)で直径8mmの穴を寒天培地に開け、穴内一杯(約0.1g)に、表1に示す各被験試料を注入し、33℃24時間培養した。培養後、阻止円の直径(mm)を測定し、平均値(n=3)を算出した。この結果を表1に示す。 Staphylococcus captis bacterial solution was spread on MH agar medium (Mueller-Hinton agar medium, petri dish diameter 9 cm) inoculated with about 10 6 CFU/mL, and sterilized perforation cutter (TOYOBO, biopsy punch 8 mm, stainless steel). ), a hole having a diameter of 8 mm was opened in the agar medium, and each test sample shown in Table 1 was injected into the hole (about 0.1 g), and cultured at 33° C. for 24 hours. After culturing, the diameter (mm) of the inhibition circle was measured, and the average value (n=3) was calculated. The results are shown in Table 1.
表1に示す試験結果から、実施例1−1のように、塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛とを併用すれば、頭皮の皮膚常在菌に対する相加的な殺菌効果は生じないことが確認された。具体的には、殺菌成分である塩化ベンザルコニウムを単独で含む比較例1−4における阻止円の大きさに比して、殺菌成分である塩化ベンザルコニウムと制汗成分であるパラフェノールスルホン酸亜鉛とを併用した実施例1−1における阻止円の大きさは拡大しておらず、相加的な殺菌効果は生じないことが確認された。 From the test results shown in Table 1, as in Example 1-1, when benzalkonium chloride and zinc paraphenolsulfonate are used in combination, no additive bactericidal effect on skin-resident bacteria of the scalp occurs. Was confirmed. Specifically, as compared with the size of the inhibition circle in Comparative Example 1-4 containing benzalkonium chloride as a bactericidal component alone, benzalkonium chloride as a bactericidal component and paraphenolsulfone as an antiperspirant component were compared. It was confirmed that the size of the inhibition circle in Example 1-1 in which zinc acid was used in combination was not enlarged, and no additive bactericidal effect was produced.
また、表1に示す試験結果から、実施例1−2のように、イソプロピルメチルフェノールとクロルヒドロキシアルミニウムとを併用すれば、頭皮の皮膚常在菌に対する相加的な殺菌効果は生じないことが確認された。具体的には、殺菌成分であるイソプロピルメチルフェノールを単独で含む比較例1−5における阻止円の大きさに比して、殺菌成分であるイソプロピルメチルフェノールと制汗成分であるクロルヒドロキシアルミニウムとを併用した実施例1−2の阻止円の大きさは拡大しておらず、相加的な殺菌効果は生じないことが確認された。 Further, from the test results shown in Table 1, if isopropylmethylphenol and chlorohydroxyaluminum are used in combination as in Example 1-2, no additive bactericidal effect on the skin-resident bacteria of the scalp may be produced. confirmed. Specifically, as compared with the size of the inhibition circle in Comparative Example 1-5 containing isopropylmethylphenol alone which is a bactericidal component, isopropylmethylphenol which is a bactericidal component and chlorhydroxyaluminum which is an antiperspirant component are compared with each other. It was confirmed that the size of the inhibition circle of Example 1-2 used in combination was not enlarged, and no additive bactericidal effect was produced.
また、表1に示す試験結果から、実施例1−3のように、塩化ベンザルコニウムとクロルヒドロキシアルミニウムとを併用すれば、頭皮の皮膚常在菌に対する相加的な殺菌効果は生じないことが確認された。具体的には、殺菌成分である塩化ベンザルコニウムを単独で含む比較例1−4における阻止円の大きさに比して、殺菌成分である塩化ベンザルコニウムと制汗成分であるクロルヒドロキシアルミニウムとを併用した実施例1−3における阻止円の大きさは拡大しておらず、相加的な殺菌効果は生じないことが確認された。 In addition, from the test results shown in Table 1, when benzalkonium chloride and chlorohydroxyaluminum are used in combination as in Example 1-3, no additive bactericidal effect against skin-resident bacteria of the scalp does not occur. Was confirmed. Specifically, compared with the size of the inhibition circle in Comparative Example 1-4 containing benzalkonium chloride as a bactericidal component alone, benzalkonium chloride as a bactericidal component and chlorhydroxyaluminum as an antiperspirant component are compared. It was confirmed that the size of the inhibition circle in Example 1-3 in which both and were used in combination was not enlarged, and no additive bactericidal effect was produced.
また、表1に示す試験結果から、実施例1−4のように、イソプロピルメチルフェノールとパラフェノールスルホン酸亜鉛とを併用すれば、頭皮の皮膚常在菌に対する相加的な殺菌効果は生じないことが確認された。具体的には、イソプロピルメチルフェノールとパラフェノールスルホン酸亜鉛のうち、阻止円が形成された成分であるパラフェノールスルホン酸亜鉛を単独で含む比較例1−2における阻止円の大きさに比して、殺菌成分であるイソプロピルメチルフェノールと制汗成分であるパラフェノールスルホン酸とを併用した実施例1−4の阻止円の大きさは拡大しておらず、相加的な殺菌効果は生じないことが確認された。 In addition, from the test results shown in Table 1, when isopropylmethylphenol and zinc paraphenolsulfonate are used in combination as in Example 1-4, no additive bactericidal effect against skin-resident bacteria of the scalp does not occur. It was confirmed. Specifically, in comparison with the size of the inhibition circle in Comparative Example 1-2, which contains isopropylmethylphenol and zinc paraphenolsulfonate alone, zinc paraphenolsulfonate, which is a component in which the inhibition circle is formed, is included. The size of the inhibition circle of Example 1-4 in which isopropylmethylphenol which is a bactericidal component and paraphenolsulfonic acid which is an antiperspirant component are used in combination has not expanded, and an additive bactericidal effect does not occur. Was confirmed.
このように、実施例1−1〜実施例1−4によれば、頭皮の皮膚常在菌であるスタフィロコッカス カプティスに対して相加的な殺菌効果は生じないため、頭皮における皮膚常在菌の生態系バランスを崩し難く、これを保持し易いという効果を奏する。 As described above, according to Examples 1-1 to 1-4, since an additive bactericidal effect does not occur against Staphylococcus captis, which is a skin resident bacteria of the scalp, the skin resident of the scalp is not present. It has the effect that the ecological balance of the fungus is not easily destroyed and that it is easily retained.
他方、表1に示す試験結果から、比較例1−7のように、ヒノキチオールとパラフェノールスルホン酸亜鉛とを併用すれば、頭皮の皮膚常在菌に対する相加的な殺菌効果が生じることが確認された。具体的には、殺菌成分であるヒノキチオールを単独で含む比較例1−3における阻止円の大きさに比して、殺菌成分であるヒノキチオールと制汗成分であるパラフェノールスルホン酸亜鉛とを併用した比較例1−7の阻止円の大きさは拡大しており、相加的な殺菌効果を生じることが確認された。 On the other hand, from the test results shown in Table 1, it was confirmed that, as in Comparative Example 1-7, when hinokitiol and zinc paraphenolsulfonate were used in combination, an additive bactericidal effect was produced against skin-resident bacteria of the scalp. Was done. Specifically, compared to the size of the inhibition circle in Comparative Example 1-3 containing hinokitiol as a bactericidal component alone, hinokitiol as a bactericidal component and zinc paraphenolsulfonate as an antiperspirant component were used in combination. The size of the inhibition circle in Comparative Example 1-7 was enlarged, and it was confirmed that an additive bactericidal effect was produced.
このように、比較例1−7は、頭皮の皮膚常在菌であるスタフィロコッカス カプティスに対して相加的な殺菌効果を生じてしまうため、頭皮における皮膚常在菌の生態系バランスに崩し易く、これを保持し難いものといえる。 As described above, Comparative Example 1-7 causes an additive bactericidal effect on Staphylococcus captis, which is a skin resident bacteria of the scalp, and thus disrupts the ecological balance of skin resident bacteria on the scalp. It can be said that it is easy and difficult to hold.
以上により、殺菌成分と制汗成分とを併用する場合、各成分の種別によっては、相加的な殺菌効果が生じ、頭皮における皮膚常在菌の生態系バランスに崩れることが確認される一方、本発明によれば、相加的な殺菌効果は生じないため、頭皮における皮膚常在菌の生態系バランスを崩し難く、これを保持し易いものであることが確認された。 From the above, when using a bactericidal component and an antiperspirant component together, depending on the type of each component, an additive bactericidal effect occurs, while it is confirmed that the ecological balance of skin-resident bacteria in the scalp is destroyed. According to the present invention, since no additive bactericidal effect is produced, it has been confirmed that the ecological balance of skin-resident bacteria in the scalp is not easily disturbed, and that it is easy to maintain this.
[試験例2.皮脂の菌代謝抑制評価]
皮脂中のトリグリセライドが皮膚常在菌によって代謝されることにより臭いの原因物質が発生することが知られている。そこで、頭皮の皮膚常在菌に対する本発明の菌代謝抑制効果を評価するために、皮脂の主成分であるトリグリセライドとしてトリオレイン、頭皮の皮膚常在菌としてスタフィロコッカス カプティス、殺菌成分としてイソプロピルメチルフェノール、塩化ベンザルコニウム及びヒノキチオール、制汗成分としてクロルヒドロキシアルミニウム及びパラフェノールスルホン酸亜鉛を用意し、以下の試験を行った。
[Test Example 2. Evaluation of inhibition of bacterial metabolism of sebum]
It is known that odor-causing substances are generated by triglyceride in sebum being metabolized by skin-resident bacteria. Therefore, in order to evaluate the bacterial metabolism inhibitory effect of the present invention on the skin resident bacteria of the scalp, triolein as the triglyceride which is the main component of sebum, Staphylococcus captis as the skin resident bacteria of the scalp, and isopropylmethyl as the bactericidal component. Phenol, benzalkonium chloride and hinokitiol, chlorohydroxyaluminum and zinc paraphenolsulfonate as antiperspirant components were prepared and the following tests were conducted.
トリプトソイ寒天培地(シャーレ 直径9cm)に、トリオレイン0.005cc/cm2及びスタフィロコッカス カプティスを菌数6.5×105/cm2となるように調整した菌液を塗布し、さらに下記の表2に示す各被験試料をシャーレ1枚当たり0.3cc塗布し、35℃3日間培養後、エーテルで抽出し、下記測定条件にてガスクロマトグラフ(GC−MS)分析を用いて、各抽出液中のオレイン酸を定量した。
なお、トリオレインが分解されることにより頭皮の臭いの原因となるオレイン酸量が増加するため、オレイン酸量が少ない程、頭皮臭が抑えられることとなる。
To tryptic soy agar medium (dishes diameter 9 cm), triolein 0.005 cc/cm 2 and Staphylococcus captis were adjusted to a bacterial count of 6.5×10 5 /cm 2, and the following bacterial solution was applied. Each test sample shown in Table 2 was coated with 0.3 cc per petri dish, cultivated at 35° C. for 3 days, extracted with ether, and extracted with gas chromatograph (GC-MS) analysis under the following measurement conditions. The oleic acid in the sample was quantified.
Since the amount of oleic acid that causes odor of the scalp increases due to the decomposition of triolein, the scalp odor is suppressed as the amount of oleic acid decreases.
<GC−MS測定条件>
・機種:アジレント・テクノロジー社製 ガスクロマトグラフ−質量分析装置(GC−MS)
GC :7890B
MS :5977A
カラム :GLサイエンス社製 HPINNOWAX 30m,0.25mmI.D.,0.25μm
キャリヤーガス:He
<GC条件>
温度:80℃⇒昇温(20℃/分)⇒260℃(6分)
流量:1mL/min
注入量:1μL
注入口:260℃
スプリット比 10:1
<MS条件>
イオン化法:電子イオン化法(EI)
<GC-MS measurement conditions>
・Model: Agilent Technologies Gas Chromatograph-Mass Spectrometer (GC-MS)
GC: 7890B
MS: 5977A
Column: HP Science Inc. HPINNOWAX 30 m, 0.25 mm I.D. D. , 0.25 μm
Carrier gas: He
<GC conditions>
Temperature: 80°C ⇒ temperature increase (20°C/min) ⇒ 260°C (6 minutes)
Flow rate: 1 mL/min
Injection volume: 1 μL
Inlet port: 260°C
Split ratio 10:1
<MS conditions>
Ionization method: Electron ionization method (EI)
なお、ブランクとして、前記菌液と各被験試料を塗布しない以外は、上記と同様の工程を行い、オレイン酸を定量した。また、コントロールとして、各被験試料を塗布しない以外は、上記と同様の工程を行い、オレイン酸を定量した。 As a blank, oleic acid was quantified by performing the same steps as above except that the bacterial solution and each test sample were not applied. Further, as a control, the same steps as described above were performed except that each test sample was not applied to quantify oleic acid.
各実施例、各比較例、及びコントロールの各定量値からブランクの定量値を減算した値を、各実施例、各比較例、及びコントロールの真のオレイン酸量とした。コントロールの真のオレイン酸量を100として、各実施例及び各比較例のオレイン酸量を求め、その結果を図1に示す。 The value obtained by subtracting the blank quantitative value from each quantitative value of each Example, each Comparative Example, and the control was taken as the true oleic acid amount of each Example, each Comparative Example, and the control. Taking the true oleic acid amount of the control as 100, the oleic acid amount of each Example and each Comparative Example was determined, and the result is shown in FIG.
図1に示す試験結果から、実施例2−1の塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛との併用によれば、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できることが確認された。具体的には、コントロールにおけるオレイン酸量に比して、塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛とを併用した実施例2−1におけるオレイン酸量は著しく減少していることから、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できることが確認された。 From the test results shown in FIG. 1, it was confirmed that the combined use of benzalkonium chloride and zinc paraphenolsulfonate of Example 2-1 can suppress the amount of triolein decomposed by the skin-resident bacteria of the scalp. .. Specifically, since the amount of oleic acid in Example 2-1 in which benzalkonium chloride and zinc paraphenolsulfonate were used in combination was remarkably reduced as compared with the amount of oleic acid in the control, the skin of the scalp It was confirmed that the amount of triolein degraded by indigenous bacteria could be suppressed.
実施例2−1の菌代謝抑制評価試験の結果、及び実施例1−1の殺菌効果評価試験の結果から、塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛との併用によれば、制汗成分の作用により汗の発生を抑制できる一方、相加的な殺菌効果を生じさせないため、頭皮における皮膚常在菌の生態系バランスを崩すことなく、且つ、頭皮における皮膚常在菌によるトリオレインの分解量を抑制できるため、頭皮の臭いを抑制でき、頭皮用制汗組成物として極めて有用であることが確認された。 From the results of the bacterial metabolism inhibition evaluation test of Example 2-1 and the bactericidal effect evaluation test of Example 1-1, according to the combined use of benzalkonium chloride and zinc paraphenolsulfonate, an antiperspirant component was obtained. While it can suppress the generation of sweat by the action, it does not cause an additive bactericidal effect, so it does not disturb the ecological balance of skin resident bacteria on the scalp and the amount of triolein decomposed by skin resident bacteria on the scalp. It was confirmed that the odor of the scalp can be suppressed because it can be suppressed, and that it is extremely useful as an antiperspirant composition for the scalp.
他方、図1に示す試験結果から、比較例2−6のヒノキチオールとクロルヒドロキシアルミニウムとの併用、比較例2−7のヒノキチオールとパラフェノールスルホン酸亜鉛との併用によれば、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できないことが確認された。具体的には、コントロールにおけるオレイン酸量に比して、ヒノキチオールとクロルヒドロキシアルミニウムとを併用した比較例2−6、及びヒノキチオールとパラフェノールスルホン酸亜鉛とを併用した比較例2−7におけるオレイン酸量は減少しておらず、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できないことが確認された。 On the other hand, from the test results shown in FIG. 1, according to the combined use of the hinokitiol of Comparative Example 2-6 and chlorohydroxyaluminum, and the combined use of the hinokitiol of Comparative Example 2-7 and zinc paraphenolsulfonate, skin resident of the scalp It was confirmed that the amount of decomposition of triolein by the fungus could not be suppressed. Specifically, as compared with the amount of oleic acid in the control, Comparative Example 2-6 in which hinokitiol and chlorohydroxyaluminum were used in combination, and oleic acid in Comparative Example 2-7 in which hinokitiol and zinc paraphenolsulfonate were used in combination. The amount did not decrease, and it was confirmed that the amount of triolein decomposed by the skin resident bacteria of the scalp could not be suppressed.
図1の比較例2−6の菌代謝抑制評価試験の結果、及び表1の比較例1−6の殺菌効果評価試験の結果から、ヒノキチオールとクロルヒドロキシアルミニウムとの併用によれば、相加的な殺菌効果を生じさせることはないが、頭皮常在菌によるトリオレインの分解量を抑制できないため、頭皮の臭いを抑制できないことが確認された。 From the results of the bacterial metabolism inhibition evaluation test of Comparative Example 2-6 in FIG. 1 and the bactericidal effect evaluation test of Comparative Example 1-6 in Table 1, according to the combined use of hinokitiol and chlorhydroxyaluminum, additive It was confirmed that the odor of the scalp could not be suppressed because the amount of triolein decomposed by the bacteria indigenous to the scalp could not be suppressed, although the bactericidal effect was not produced.
図1の比較例2−7の菌代謝抑制評価試験の結果、及び表1の比較例1−7の殺菌効果評価試験の結果から、ヒノキチオールとパラフェノールスルホン酸亜鉛との併用によれば、相加的な殺菌効果が生じてしまい、頭皮における皮膚常在菌の生態系バランスを崩し易く、且つ、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できないため、頭皮の臭いを抑制できないことが確認された。 From the results of the bacterial metabolism inhibition evaluation test of Comparative Example 2-7 of FIG. 1 and the bactericidal effect evaluation test of Comparative Example 1-7 of Table 1, according to the combined use of hinokitiol and zinc paraphenolsulfonate, An additional bactericidal effect is generated, it is easy to disturb the ecological balance of skin resident bacteria on the scalp, and it is not possible to suppress the odor of the scalp because the amount of triolein decomposed by the skin resident bacteria of the scalp cannot be suppressed. Was confirmed.
以上により、殺菌成分と制汗成分とを併用する場合、各成分の種別によっては、相加的な殺菌効果が生じ、頭皮における皮膚常在菌の生態系バランスが崩れ、且つ、頭皮の臭いを抑制できないことが確認された。これに対し、本発明のように特定の殺菌成分と制汗成分との併用によれば、汗の発生を抑制すると共に、相加的な殺菌効果を生じさせないため、頭皮における皮膚常在菌の生態系バランスを崩し難く、これを保持し易いものであり、且つ、頭皮における皮膚常在菌によるトリオレインの分解量を抑制できるため、頭皮の臭いを抑制できることが確認された。 From the above, when using a bactericidal component and an antiperspirant component together, depending on the type of each component, an additive bactericidal effect occurs, the ecological balance of skin-resident bacteria in the scalp is upset, and the odor of the scalp It was confirmed that it could not be suppressed. On the other hand, according to the combined use of a specific bactericidal component and an antiperspirant component as in the present invention, while suppressing the generation of sweat, because it does not produce an additive bactericidal effect, skin resident bacteria of the scalp It has been confirmed that the balance of the ecosystem is difficult to be destroyed and is easily maintained, and the amount of triolein decomposed by skin-resident bacteria on the scalp can be suppressed, so that the odor of the scalp can be suppressed.
[試験例3.皮脂の菌代謝抑制評価]
種別の異なる殺菌成分を併用することは、例えば、皮膚に存する皮脂量の多寡など様々な皮膚の状態に適した殺菌効果を発揮させるなどの観点から重要である。そこで、複数の殺菌成分を含む場合の本発明における菌代謝抑制効果を評価するために、表3に示すとおり、殺菌成分と制汗成分とを含む被験試料と、前記被験試料に対して、さらに種別の異なる殺菌成分を配合した被験試料を各々用意し、以下の試験を行った。
[Test Example 3. Evaluation of inhibition of bacterial metabolism of sebum]
The combined use of different types of bactericidal components is important from the viewpoint of exhibiting a bactericidal effect suitable for various skin conditions such as the amount of sebum present in the skin. Therefore, in order to evaluate the bacterial metabolism inhibitory effect in the present invention in the case of containing a plurality of bactericidal components, as shown in Table 3, a test sample containing a bactericidal component and an antiperspirant component, and further to the test sample, Each test sample prepared by mixing different types of bactericidal components was prepared, and the following tests were conducted.
トリプトソイ寒天培地(シャーレ 直径9cm)に、トリオレイン0.005cc/cm2及びスタフィロコッカス カプティスを菌数6.5×105/cm2となるように調整した菌液を塗布し、さらに表3に示す各被験試料をシャーレ1枚当たり0.3cc塗布し、35℃3日間培養後、エーテルで抽出し、ガスクロマトグラフ(GC−MS)分析を用いて、各抽出液中のオレイン酸を定量した。なお、ガスクロマトグラフ(GC−MS)の測定条件は、試験例2と同様である。 To tryptoso agar medium (dishes diameter 9 cm), 0.005 cc/cm 2 of triolein and Staphylococcus captis were applied to a bacterial solution adjusted to a number of 6.5×10 5 /cm 2, and then Table 3 Each test sample shown in 3 was coated with 0.3 cc per petri dish, cultured at 35° C. for 3 days, extracted with ether, and oleic acid in each extract was quantified using gas chromatograph (GC-MS) analysis. .. The measurement conditions of the gas chromatograph (GC-MS) are the same as in Test Example 2.
定量された比較例3−1のオレイン酸量を100(基準)として、実施例3−1及び実施例3−2のオレイン酸量を求め、その結果を図2に示す。 With the quantified amount of oleic acid of Comparative Example 3-1 being 100 (reference), the amounts of oleic acid of Example 3-1 and Example 3-2 were determined, and the results are shown in FIG.
図2に示す試験結果から、実施例3−2の塩化ベンザルコニウム、イソプロピルメチルフェノール、パラフェノールスルホン酸亜鉛の組み合わせによれば、実施例3−1の塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛の組み合わせと同等程度に、頭皮の皮膚常在菌によるトリオレインの分解量を抑制できることが確認された。具体的には、例えば、ヒノキチオールのように菌代謝を抑制できず、逆に菌代謝を促進させる殺菌成分が存在するため(試験例2の比較例2−3参照)、組み合わせる殺菌成分の種別によっては、菌代謝抑制効果が損なわれる恐れがあるところ、実施例3−2のように、殺菌成分として塩化ベンザルコニウム、制汗成分としてパラフェノールスルホン酸亜鉛を含み、さらに、殺菌成分としてイソプロピルメチルフェノールを含むものによれば、菌代謝抑制効果が損なわれないことが確認された。 From the test results shown in FIG. 2, according to the combination of benzalkonium chloride, isopropylmethylphenol and zinc paraphenolsulfonate of Example 3-2, benzalkonium chloride and zinc paraphenolsulfonate of Example 3-1 were used. It was confirmed that the amount of triolein decomposed by the skin resident bacteria of the scalp could be suppressed to the same extent as that of the combination. Specifically, for example, since there is a bactericidal component such as hinokitiol that cannot suppress the bacterial metabolism and promotes the bacterial metabolism (see Comparative Example 2-3 of Test Example 2), depending on the type of the bactericidal component to be combined. Where bactericidal metabolism suppressing effect may be impaired, as in Example 3-2, benzalkonium chloride as a bactericidal component, zinc paraphenolsulfonate as an antiperspirant component, and isopropylmethyl as a bactericidal component are further included. It was confirmed that those containing phenol do not impair the bacterial metabolism suppressing effect.
以上により、実施例3−2の塩化ベンザルコニウム、イソプロピルメチルフェノール、パラフェノールスルホン酸亜鉛の組み合わせによれば、頭皮における皮膚常在菌によるトリオレインの分解量を抑制できるため、頭皮の臭いを抑制できることが確認されると共に、種別の異なる殺菌成分を用いることにより、例えば、皮膚に存する皮脂量の多寡など、様々な皮膚の状態に適した殺菌効果を発揮し得ることが確認された。 As described above, according to the combination of benzalkonium chloride, isopropylmethylphenol, and zinc paraphenolsulfonate of Example 3-2, the amount of triolein decomposed by the skin-resident bacteria in the scalp can be suppressed, and thus the odor of the scalp can be reduced. It was confirmed that it can be suppressed, and it was confirmed that the use of different types of bactericidal components can exert a bactericidal effect suitable for various skin conditions such as the amount of sebum present in the skin.
[試験例4.製剤の使用性評価試験]
本発明の使用性を評価するため、以下の試験を行った。
市販の人工皮革(出光テクノファイン社製、サプラーレ PBZ13001)2cm×15cmにホホバ油(日光ケミカルズ社製、NIKKOLホホバ油S)を15μL塗布したものを略垂直に設置し、表4に示す各製剤例5μLを滴下し、15秒後の垂れた長さ(cm)を測定した。その結果を、表4に示す。なお、以下の実施例及び比較例における配合量はw/w%である。
[Test Example 4. Drug Product Usability Evaluation Test]
The following tests were conducted to evaluate the usability of the present invention.
Commercially available artificial leather (Idemitsu Techno Fine Co., Suprare PBZ13001) 2 cm×15 cm coated with 15 μL of jojoba oil (Nikko Chemicals Co., Ltd., NIKKOL Jojoba Oil S) was placed almost vertically, and each formulation example shown in Table 4 was obtained. 5 μL was dropped, and the dripping length (cm) after 15 seconds was measured. The results are shown in Table 4. In addition, the compounding quantity in the following Examples and Comparative Examples is w/w %.
表4に示す試験結果から、実施例4−1及び実施例4−2のように、塩化ベンザルコニウムと、クロルヒドロキシアルミニウム又はパラフェノールスルホン酸亜鉛を含む製剤によれば、意外にも垂れ具合を改善できることが確認された。具体的には、塩化ベンザルコニウムとクロルヒドロキシアルミニウムとを併用した実施例4−1、塩化ベンザルコニウムとパラフェノールスルホン酸亜鉛とを併用した実施例4−2における垂れ長さは、各成分単体である比較例4−1、比較例4−2及び比較例4−3に比して減少しているため、不快感がなく、頭皮における使用性が良好であることが確認された。 From the test results shown in Table 4, according to the formulation containing benzalkonium chloride and chlorohydroxyaluminum or zinc paraphenolsulfonate as in Examples 4-1 and 4-2, the drooping condition was unexpectedly high. It was confirmed that the above can be improved. Specifically, the sagging length in Example 4-1 in which benzalkonium chloride and chlorohydroxyaluminum are used in combination and in Example 4-2 in which benzalkonium chloride and zinc paraphenolsulfonate are used in combination are It was confirmed that there was no discomfort and the usability on the scalp was good because the amount was smaller than that of Comparative Examples 4-1, 4-2 and 4-3, which were single substances.
また、表4に示す試験結果から、実施例4−3及び実施例4−4のように、イソプロピルメチルフェノールと、クロルヒドロキシアルミニウム又はパラフェノールスルホン酸亜鉛を含む製剤によれば、意外にも垂れ具合を改善できることが確認された。具体的には、イソプロピルメチルフェノールとクロルヒドロキシアルミニウムとを併用した実施例4−3、イソプロピルメチルフェノールとパラフェノールスルホン酸亜鉛とを併用した実施例4−4における垂れ長さは、各成分単体である比較例4−1、比較例4−2及び比較例4−4に比して減少しているため、不快感がなく、頭皮における使用性が良好であることが確認された。 In addition, from the test results shown in Table 4, according to the formulations containing isopropylmethylphenol and chlorohydroxyaluminum or zinc paraphenolsulfonate as in Examples 4-3 and 4-4, it was unexpectedly dripping. It was confirmed that the condition could be improved. Specifically, the sagging length in Example 4-3 in which isopropylmethylphenol and chlorohydroxyaluminum are used in combination and in Example 4-4 in which isopropylmethylphenol and zinc paraphenolsulfonate are used in combination It was confirmed that there was no discomfort and the usability on the scalp was good because the amount was decreased as compared with Comparative Examples 4-1, 4-2 and 4-4.
さらに、表4に示す試験結果から、実施例4−5及び実施例4−6のように、グリチルレチン酸と、クロルヒドロキシアルミニウム又はパラフェノールスルホン酸亜鉛を含む製剤によれば、意外にも垂れ具合を改善できることが確認された。具体的には、グリチルレチン酸とクロルヒドロキシアルミニウムとを併用した実施例4−5、グリチルレチン酸とパラフェノールスルホン酸亜鉛とを併用した実施例4−6における垂れ長さは、各成分単体である比較例4−1、比較例4−2及び比較例4−5に比して減少しているため、不快感がなく、頭皮における使用性が良好であることが確認された。 Furthermore, from the test results shown in Table 4, as in Examples 4-5 and 4-6, according to the formulation containing glycyrrhetinic acid and chlorohydroxyaluminum or zinc paraphenolsulfonate, the drooping condition was unexpectedly high. It was confirmed that the above can be improved. Specifically, the sagging lengths in Examples 4-5 in which glycyrrhetinic acid and chlorohydroxyaluminum are used in combination and in Examples 4-6 in which glycyrrhetinic acid and zinc paraphenolsulfonate are used in combination are the respective components alone. It was confirmed that there was no discomfort and the usability on the scalp was good because the amount was smaller than those in Example 4-1, Comparative Example 4-2 and Comparative Example 4-5.
[試験例5.製剤の使用性及び使用感評価試験]
本発明の使用性及び使用感を評価するため、表5に記載の各製剤例について、上記試験例4と同様の使用性評価試験(製剤の垂れた長さの評価)及び下記の使用感評価試験を行った。
使用感評価は、ミスト状に噴霧できる一般的なトリガータイプのスプレーボトル(噴霧量0.3mL〜0.5mL)に各製剤例を充填し、専門パネラー5名が、頭皮から5cmの距離より頭皮に1プッシュずつ噴霧し、「頭皮のべたつかなさ」、「頭皮のスッキリ感」、「速乾感」の3項目について、1〜10の10段階で評価した。各数値が高いほど評価が高いことを示す。パネラー5名の評価結果の平均点を算出し、以下に示す基準により評価した。その結果を表5に示す。
以下の実施例及び比較例における配合量はw/w%である。
[評価基準]
◎:7点以上
○:5点以上7点未満
△:3.5点以上5点未満
×:3.5点未満
[Test Example 5. Formulation usability and usability evaluation test]
In order to evaluate the usability and feeling of use of the present invention, for each formulation example shown in Table 5, the same usability evaluation test (evaluation of the drooping length of the formulation) and the following usability evaluation were performed as in Test Example 4 above. The test was conducted.
To evaluate the feeling of use, each formulation example was filled in a general trigger-type spray bottle (spray amount 0.3 mL to 0.5 mL) that can be sprayed in the form of mist, and 5 specialized panelists took the scalp from a distance of 5 cm from the scalp. Each one push was sprayed onto the skin, and the three items of "stickiness of scalp", "clean feeling of scalp", and "quick dry feeling" were evaluated on a scale of 1 to 10. The higher each value is, the higher the evaluation is. The average score of the evaluation results of 5 panelists was calculated and evaluated according to the following criteria. The results are shown in Table 5.
The compounding amount in the following examples and comparative examples is w/w%.
[Evaluation criteria]
◎: 7 points or more ○: 5 points or more and less than 7 points △: 3.5 points or more and less than 5 points ×: Less than 3.5 points
表5に示す試験結果から、実施例5−1のように、塩化ベンザルコニウムと、クロルヒドロキシアルミニウムを含み、さらに粉体であるトウモロコシデンプン、清涼成分であるl−メントールを含む製剤によれば、意外にも垂れ具合を改善できるだけでなく、特に優れた使用感を得られることが確認された。また、実施例5−2のように、パラフェノールスルホン酸亜鉛と、イソプロピルメチルフェノールを含み、さらに粉体であるタルク、清涼成分であるl−メントールを含む製剤によれば、意外にも垂れ具合を改善できるだけでなく、優れた使用感を得られることが確認された。他方、実施例5−1に比してクロルヒドロキシアルミニウムを含まない点でのみ異なる比較例5−1は、実施例5−1に比して垂れ長さ、使用感のいずれにおいても劣ることが確認された。 From the test results shown in Table 5, as in Example 5-1, according to the formulation containing benzalkonium chloride and chlorohydroxyaluminum, corn starch as a powder, and 1-menthol as a cooling component, It was confirmed that not only the dripping condition can be improved unexpectedly, but also a particularly excellent feeling of use can be obtained. Further, as in Example 5-2, according to the formulation containing zinc paraphenolsulfonate, isopropylmethylphenol, talc which is a powder, and l-menthol which is a cooling component, the drooping condition is unexpectedly high. It was confirmed that not only can it be improved, but also an excellent usability can be obtained. On the other hand, Comparative Example 5-1 which differs from Example 5-1 only in not containing chlorohydroxyaluminum may be inferior to Example 5-1 in both the sagging length and the feeling of use. confirmed.
以上により、特定の殺菌成分と、制汗成分とを併用する本発明によれば、汗の発生を抑制すると共に、頭皮における皮膚常在菌の生態系バランスを崩し難く、頭皮の臭いを抑制できる。すなわち、頭皮の汗臭に加え、汗と皮脂が混在することで生じる酸化臭や、皮脂の分解又は皮膚常在菌による代謝によって排出される脂肪酸臭など、頭皮の臭いを総合的に抑制することができ得る。
また、これに加えて、さらに、頭皮における使用性が良好であるという顕著な効果を奏することが確認された。
また、特定の殺菌成分と制汗成分とを併用する本発明において、さらに粉体や清涼成分を配合すれば、使用感が良好であるという顕著な効果を奏することが確認された。
As described above, according to the present invention in which a specific bactericidal component and an antiperspirant component are used in combination, it is possible to suppress the occurrence of sweat, and it is difficult to disturb the ecological balance of skin-resident bacteria in the scalp, and the odor of the scalp can be suppressed. .. That is, in addition to the sweat odor of the scalp, comprehensively suppress the odor of the scalp, such as the oxidative odor caused by the mixture of sweat and sebum, and the fatty acid odor discharged by the decomposition of sebum or the metabolism by the skin-resident bacteria. Can be done.
In addition to this, it was further confirmed that a remarkable effect that the usability on the scalp was good was exhibited.
In addition, in the present invention in which a specific bactericidal component and an antiperspirant component are used in combination, it has been confirmed that when a powder or a refreshing component is further mixed, a remarkable effect that a feeling of use is good is exhibited.
以下、本発明の頭皮用制汗組成物の製剤処方例を示す。なお、以下の製剤処方例における配合量はw/w%である。 Hereinafter, formulation examples of the antiperspirant composition for scalp of the present invention will be shown. In addition, the compounding quantity in the following formulation examples is w/w%.
(製剤処方例1) (液剤)(ミストタイプ)
イソプロピルメチルフェノール 0.1%
クロルヒドロキシアルミニウム 10%
エタノール 70%
ヒドロキシエチルセルロース 0.2%
l−メントール 0.3%
緑茶エキス 0.1%
香料(ソープ系) 適量
水 残量
(Preparation example 1) (Liquid formulation) (Mist type)
Isopropylmethylphenol 0.1%
Chlorhydroxyaluminum 10%
70% ethanol
Hydroxyethyl cellulose 0.2%
l-menthol 0.3%
Green tea extract 0.1%
Fragrance (soap type) Appropriate amount of water Remaining amount
(製剤処方例2) (液剤)(ロールオンタイプ)
塩化ベンザルコニウム 0.1%
パラフェノールスルホン酸亜鉛 3%
エタノール 50%
ヒドロキシプロピルメチルセルロース 0.2%
l−メントール 0.2%
l−メンチルグリセリルエーテル 0.1%
ハマメリスエキス 0.1%
ノイバラエキス 0.1%
オクテニルコハク酸デンプンアルミニウム 5%
香料(スイートフローラル系) 適量
水 残量
(Formulation example 2) (Liquid formulation) (Roll-on type)
Benzalkonium chloride 0.1%
Zinc paraphenol sulfonate 3%
50% ethanol
Hydroxypropyl methylcellulose 0.2%
l-menthol 0.2%
l-menthyl glyceryl ether 0.1%
Hamamelis extract 0.1%
Neubara extract 0.1%
Starch aluminum octenyl succinate 5%
Fragrance (sweet floral type) Appropriate amount of water Remaining amount
(製剤処方例3)(液剤)(滴下タイプ)
グリチルレチン酸 0.1%
クロルヒドロキシアルミニウム 15%
エタノール 50%
キサンタンガム 0.2%
柿タンニン 0.1%
緑茶エキス 0.1%
センブリエキス 0.1%
パラベン 0.2%
水 残量
(Pharmaceutical formulation example 3) (Liquid formulation) (Drop type)
Glycyrrhetinic acid 0.1%
Chlorhydroxyaluminum 15%
50% ethanol
Xanthan gum 0.2%
Persimmon tannin 0.1%
Green tea extract 0.1%
Assembly extract 0.1%
Paraben 0.2%
Water remaining
(製剤処方例4)(液剤)(ブラシタイプ)
塩化ベンザルコニウム 0.05%
イソプロピルメチルフェノール 0.1%
パラフェノールスルホン酸亜鉛 1%
エタノール 20%
カラギーナン 0.3%
1,3−ブチレングリコール 10%
カチオン化セルロース 1%
ポリオキシエチレン硬化ヒマシ油 0.5%
酢酸トコフェロール 0.1%
ヨモギエキス 0.1%
水 残量
(Formulation prescription example 4) (liquid) (brush type)
Benzalkonium chloride 0.05%
Isopropylmethylphenol 0.1%
Zinc paraphenol sulfonate 1%
Ethanol 20%
Carrageenan 0.3%
1,3-butylene glycol 10%
Cationized cellulose 1%
Polyoxyethylene hydrogenated castor oil 0.5%
Tocopherol acetate 0.1%
Mugwort extract 0.1%
Water remaining
(製剤処方例5)(乳液)(ボトルタイプ)
トリクロサン 0.1%
塩化ベンゼトニウム 0.05%
塩化アルミニウム 5%
セバシン酸ジエチル 2%
流動パラフィン 2%
ソルビタンモノステアレート 0.5%
ポリソルベート60 0.7%
エタノール 10%
カルボキシビニルポリマー 0.2%
フェノキシエタノール 0.3%
ナイロン末 1%
アロエエキス 0.1%
トリエタノールアミン 適量
水 残量
(Formulation example 5) (Emulsion) (Bottle type)
Triclosan 0.1%
Benzethonium chloride 0.05%
Aluminum chloride 5%
Diethyl sebacate 2%
Liquid paraffin 2%
Sorbitan monostearate 0.5%
Polysorbate 60 0.7%
Ethanol 10%
Carboxy vinyl polymer 0.2%
Phenoxyethanol 0.3%
Nylon powder 1%
Aloe extract 0.1%
Triethanolamine Appropriate amount of water Remaining amount
(製剤処方例6) (エアゾール剤、(液剤:噴射剤=1:1))
塩化ベンザルコニウム 0.03%
イソプロピルメチルフェノール 0.03%
クロルヒドロキシアルミニウム 10%
エタノール 30%
l−メントール 0.1%
l−メンチルグリセリルエーテル 0.05%
ハマメリスエキス 0.1%
ノイバラエキス 0.1%
タルク 5%
トウモロコシデンプン 3%
香料(フレッシュシトラス系) 適量
水 残量
DME 50%
(Formulation Example 6) (Aerosol, (liquid: propellant = 1:1))
Benzalkonium chloride 0.03%
Isopropylmethylphenol 0.03%
Chlorhydroxyaluminum 10%
Ethanol 30%
l-menthol 0.1%
1-menthyl glyceryl ether 0.05%
Hamamelis extract 0.1%
Neubara extract 0.1%
Talc 5%
Corn starch 3%
Fragrance (fresh citrus system) Appropriate amount of water DME 50% remaining amount
(製剤処方例7) (エアゾール剤、(液剤:噴射剤=6:4))
塩化ベンゼトニウム 0.03%
トリクロロカルバニリド 0.03%
パラフェノールスルホン酸亜鉛 2%
エタノール 40%
l−メントール 0.1%
l−メンチルグリセリルエーテル 0.05%
ハマメリスエキス 0.1%
カミツレエキス 0.1%
ナイロン末 5%
オクテニルコハク酸デンプンアルミニウム 3%
香料(シトラスハーブ系) 適量
水 残量
LPG 40%
(Formulation Formulation Example 7) (Aerosol, (Liquid: Propellant = 6:4))
Benzethonium chloride 0.03%
Trichlorocarbanilide 0.03%
Zinc paraphenol sulfonate 2%
40% ethanol
l-menthol 0.1%
1-menthyl glyceryl ether 0.05%
Hamamelis extract 0.1%
Chamomile extract 0.1%
Nylon powder 5%
Starch octenyl succinate aluminum 3%
Fragrance (citrus herb type) Appropriate amount of water LPG 40% remaining
(製剤処方例8) (ドライシャンプー)(エアゾール剤、(液剤:噴射剤=6:4))
イソプロピルメチルフェノール 0.01%
パラフェノールスルホン酸亜鉛 0.5%
エタノール 30%
l−メントール 0.1%
l−メンチルグリセリルエーテル 0.05%
ハマメリスエキス 0.1%
カミツレエキス 0.1%
シリカ 5%
マイカ 3%
香料(ヴァーベナ系) 適量
水 残量
LPG 40%
(Formulation Example 8) (Dry shampoo) (aerosol, (liquid: propellant=6:4))
Isopropyl methylphenol 0.01%
Zinc paraphenol sulfonate 0.5%
Ethanol 30%
l-menthol 0.1%
1-menthyl glyceryl ether 0.05%
Hamamelis extract 0.1%
Chamomile extract 0.1%
Silica 5%
Mica 3%
Fragrance (Verbena system) Appropriate amount of water Remaining amount LPG 40%
(製剤処方例9) (ドライシャンプー)(ミストタイプ)
塩化ベンザルコニウム 0.01%
イソプロピルメチルフェノール 0.01%
クロルヒドロキシアルミニウム 1%
エタノール 30%
l−メントール 0.3%
チャエキス 0.1%
エイジツエキス 0.1%
シャクヤクエキス 0.1%
タルク 5%
マイカ 3%
香料(ゼラニウム系) 適量
水 残量
(Formulation example 9) (Dry shampoo) (Mist type)
Benzalkonium chloride 0.01%
Isopropyl methylphenol 0.01%
Chlorhydroxyaluminum 1%
Ethanol 30%
l-menthol 0.3%
Cha extract 0.1%
Age extract 0.1%
Peony extract 0.1%
Talc 5%
Mica 3%
Fragrance (Geranium-based) Appropriate amount of water Remaining amount
(製剤処方例10) (拭き取りシート)
(シート基材:コットン、レーヨン、ポリエステル合成繊維)
塩化ベンザルコニウム 0.01%
クロルヒドロキシアルミニウム 5%
エタノール 30%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1%
l−メントール 0.2%
シャクヤクエキス 0.1%
オウゴンエキス 0.1%
コンフリーエキス 0.1%
香料(シトラス系) 適量
水 残量
(Formulation Example 10) (Wiping sheet)
(Sheet base material: cotton, rayon, polyester synthetic fiber)
Benzalkonium chloride 0.01%
Chlorhydroxyaluminum 5%
Ethanol 30%
Polyoxyethylene polyoxypropylene decyl tetradecyl ether
1%
l-menthol 0.2%
Peony extract 0.1%
Scutellaria extract 0.1%
Comfrey extract 0.1%
Fragrance (Citrus type) Appropriate amount of water Remaining amount
(製剤処方例11) (乳液含浸拭き取りシート)
(シート基材:セルロース)
イソプロピルメチルフェノール 0.05%
パラフェノールスルホン酸亜鉛 3%
シュガースクワラン 2%
トリ(カプリル/カプリン酸)グリセリル 1%
シクロヘキサン−1,4−ジカルボン酸ビスエトキシジグリコール
0.3%
メチルポリシロキサン 0.5%
キサンタンガム 0.1%
ポリオキシエチレン硬化ひまし油 0.5%
親油型モノステアリン酸グリセリル 0.3%
l−メントール 0.5%
海藻エキス 0.1%
アーティチョークエキス 0.1%
オウゴンエキス 0.1%
チャ乾留液 0.1%
センブリエキス 0.01%
ニンジンエキス 0.01%
ケイ皮エキス 0.01%
水 残量
(Formulation Example 11) (Emulsion-impregnated wiping sheet)
(Sheet base material: cellulose)
Isopropyl methylphenol 0.05%
Zinc paraphenol sulfonate 3%
Sugar squalane 2%
Tri(capryl/capric acid) glyceryl 1%
Cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol
0.3%
Methyl polysiloxane 0.5%
Xanthan gum 0.1%
Polyoxyethylene hydrogenated castor oil 0.5%
Lipophilic type glyceryl monostearate 0.3%
l-menthol 0.5%
Seaweed extract 0.1%
Artichoke extract 0.1%
Scutellaria extract 0.1%
Cha dry distillation liquid 0.1%
Assembly extract 0.01%
Carrot extract 0.01%
Cay skin extract 0.01%
Water remaining
(製剤処方例12)(液剤)(ミストタイプ)
イソプロピルメチルフェノール 0.05%
パラフェノールスルホン酸亜鉛 3%
エタノール 50%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1%
(エイコサン二酸/テトラデカン二酸)デカグリセリル
0.5%
l−メンチルグリセリルエーテル 0.2%
l−メントール 0.5%
リゾチーム塩酸塩 0.1%
チャ乾留液 0.1%
海藻エキス 0.01%
ユキノシタエキス 0.01%
チャエキス 0.01%
ハマメリスエキス 0.01%
シャクヤクエキス 0.01%
香料(ボタニカルフローラル系) 0.05%
水 残量
(Formulation Example 12) (Liquid formulation) (Mist type)
Isopropyl methylphenol 0.05%
Zinc paraphenol sulfonate 3%
50% ethanol
Polyoxyethylene polyoxypropylene decyl tetradecyl ether
1%
(Eicosanedioic acid/tetradecanedioic acid) Decaglyceryl
0.5%
l-menthyl glyceryl ether 0.2%
l-menthol 0.5%
Lysozyme hydrochloride 0.1%
Cha dry distillation liquid 0.1%
Seaweed extract 0.01%
Yukinoshita extract 0.01%
Cha extract 0.01%
Hamamelis extract 0.01%
Peony extract 0.01%
Fragrance (botanical floral type) 0.05%
Water remaining
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019016125 | 2019-01-31 | ||
JP2019016125 | 2019-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020125291A true JP2020125291A (en) | 2020-08-20 |
Family
ID=72084695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020013996A Pending JP2020125291A (en) | 2019-01-31 | 2020-01-30 | Antiperspirant composition for scalp |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2020125291A (en) |
-
2020
- 2020-01-30 JP JP2020013996A patent/JP2020125291A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7020941B2 (en) | Cosmetics | |
JP6960743B2 (en) | Small molecule silicone alternative oil | |
JP6976146B2 (en) | Wax-like composition | |
JP6033587B2 (en) | Polyester and cosmetics using the same | |
JP6912772B2 (en) | Hyaluronic acid production promoter and cosmetics containing it | |
JP6971072B2 (en) | Cosmetic composition containing mannosyl erythritol lipid | |
JP6803732B2 (en) | Cosmetics containing γ-oryzanol | |
JP2022079579A (en) | Cosmetic | |
JP6836017B2 (en) | Topical skin composition | |
JP6894207B2 (en) | Tranexamic acid-containing cosmetics or topical skin preparations | |
JP2007045776A (en) | Humectant and cosmetic and skin care preparation for external use by using the same | |
CN113015515B (en) | Cosmetic product | |
JP2009073932A (en) | Oligomer ester and composition | |
JP7084117B2 (en) | Cosmetics or skin external preparations containing 1,4-anhydroerythritol | |
JP2009057350A (en) | Antimicrobial agent, antimicrobial cosmetics and skin care preparation including the same | |
JP2020158400A (en) | O/w emulsion composition | |
JP2013067594A (en) | Cosmetic containing prunus persica gum | |
JP2009035500A (en) | Cosmetic and external preparation for skin | |
JP2020176067A (en) | Cosmetic or skin care external preparation containing phosphatidylinositol | |
JP2020002055A (en) | Cosmetics containing novel malate | |
JP7084164B2 (en) | Cosmetics containing sparingly soluble ingredients | |
JP2021169433A (en) | Topical skin preparation | |
JP2016088882A (en) | External preparation | |
JP2020117500A (en) | External composition for skin | |
JP5602456B2 (en) | Ascorbic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200130 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240426 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240426 |